Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1050.Time spend outdoors in summer,49755,0.016821169549879,0.0209555447944454,-0.024251698247234,0.057894037346992,0.422153190063875
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1060.Time spent outdoors in winter,47673,-0.00326884970705805,0.0230545217007745,-0.0484557122405761,0.04191801282646,0.88724917366992
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1070.Time spent watching television (TV),50921,0.0799935627020254,0.0212352134949263,0.0383725442519699,0.121614581152081,0.000165640955761561
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1080.Time spent using computer,47721,-0.0839693788466525,0.0205977604232618,-0.124340989276246,-0.0435977684170593,4.58844448923909e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1090.Time spent driving,43600,-0.0947430649507853,0.0239823377682259,-0.141748446976508,-0.0477376829250626,7.83482910023915e-05
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1160.Sleep duration,51704,0.0106561378727589,0.0186179218016327,-0.0258349888584411,0.0471472646039589,0.567084401913367
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35473,-0.00744725099736684,0.0281596399537903,-0.0626401453067959,0.0477456433120622,0.791429987651924
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35473,0.00526631412476132,0.0267805181652211,-0.047223501479072,0.0577561297285947,0.84410998950592
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35473,-0.0034314446549667,0.0292241578719934,-0.0607107940840738,0.0538479047741404,0.90653250890181
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35473,-0.0384759556570405,0.0293484764808153,-0.0959989695594384,0.0190470582453575,0.189904520879917
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35473,-0.00353281181274645,0.0295867629018573,-0.0615228671003868,0.0544572434748939,0.904958202641533
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35473,0.0379002382919857,0.0744506060898437,-0.108022949644108,0.183823426228079,0.610724170161766
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35473,-0.0328233972077751,0.0796147821997918,-0.188868370319367,0.123221575903817,0.680149985503292
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35473,0.0639211673926489,0.0498410151469694,-0.0337672222954112,0.161609557080709,0.199714187676542
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35473,0.0364213804146806,0.0366660165134635,-0.0354440119517078,0.108286772781069,0.32058841942316
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35473,0.0298420638676868,0.0239289358782789,-0.0170586504537398,0.0767427781891134,0.21240293612465
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35473,0.0232392162889846,0.0361061916816171,-0.047528919406985,0.0940073519849542,0.519835518722258
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35473,0.0428078905635179,0.0193200054860283,0.00494067981090242,0.0806751013161333,0.0267458203097019
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35473,-0.00463620380187381,0.0252498572707562,-0.054125924052556,0.0448535164488083,0.854322938101741
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35473,-0.016216697459262,0.0363881177264192,-0.0875374082030435,0.0551040132845196,0.655858844804898
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35473,-0.0286592167037992,0.0340515155134783,-0.0954001871102166,0.0380817537026181,0.400019913973395
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35473,0.00337628299750012,0.0526622914891429,-0.0998418083212199,0.10659437431622,0.94888311546304
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35473,-0.0114124954567962,0.0498384059081088,-0.10909577103669,0.0862707801230971,0.818884163560695
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35473,0.0355082976282226,0.0263305316321142,-0.0160995443707213,0.0871161396271664,0.17752702357546
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35473,0.0288685849243871,0.0248716347689453,-0.0198798192227457,0.0776169890715199,0.245806765334711
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35473,-0.0251994805887349,0.0316769186557535,-0.0872862411540117,0.0368872799765419,0.426343754508072
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120040.Fatigue severity over the past week,35476,0.107376017851455,0.036837924832974,0.0351736851788258,0.179578350524084,0.00357148332925754
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120041.Waking unrefreshed severity over the past week,35474,0.0599368772923824,0.0364886303762263,-0.0115808382450212,0.131454592829786,0.100512096500417
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120042.Cognitive symptoms severity over the past week,35476,0.039072430395475,0.0388161410828594,-0.0370072061269294,0.115152066917879,0.314164543870103
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120098.Mobility problems today,35480,0.0899188890006781,0.0401857171155873,0.0111548834541269,0.168682894547229,0.0252831571542119
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120099.Self-care problems today,35480,0.081884364285722,0.0616627625505195,-0.0389746503132962,0.20274337888474,0.184246621437552
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120100.Problems doing usual activities,35480,0.117138228552139,0.039131137375396,0.0404411992963633,0.193835257807915,0.00276890196880306
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120101.Pain or discomfort today,35480,0.0714442706877368,0.0363609140868986,0.000176879077415579,0.142711662298058,0.0494739159231607
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120102.Anxiety or depression today,35480,-0.0388400638267215,0.0462310358893877,-0.129452894169921,0.0517727665164784,0.400867667071528
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120103.Scale to indicate how health is today,35460,-0.0204147008670635,0.00847727268285772,-0.0370301553254647,-0.00379924640866238,0.0160614799256352
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35455,0.0132171852621956,0.0472052365298123,-0.0793050783362366,0.105739448860628,0.779491324075436
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35445,-0.0493200519019028,0.0490316268635447,-0.145422040554451,0.0467819367506448,0.314511076804344
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35461,0.049927049221701,0.0370899637757647,-0.0227692797787978,0.1226233782222,0.178316808086864
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35460,0.105783710853344,0.0377887179870993,0.0317178235986298,0.179849598108059,0.00513628633071996
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35471,0.0631469802131844,0.054893172428317,-0.044443637746317,0.170737598172686,0.250038936470357
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120109.Feeling bad about self over the last two weeks,35452,-0.0467130442870692,0.053052110104867,-0.150695180092609,0.0572690915184702,0.378615578743757
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120110.Trouble concentrating over the last two weeks,35464,-0.00192685174561408,0.052425625177238,-0.104681077093,0.100827373601772,0.970682317508184
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35463,-0.0686357191152849,0.072453404188032,-0.210644391323828,0.0733729530932577,0.343518171306574
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35442,-0.0444311616211469,0.110170069338267,-0.260364497524151,0.171502174281857,0.686744199489497
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33352,0.0217308762882607,0.0517250726255819,-0.0796502660578799,0.123112018634401,0.674417551568214
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49942,0.0792147618588882,0.0464391680046839,-0.0118060074302922,0.170235531148069,0.0880649872042663
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48191,0.00695034100224097,0.0284570908526898,-0.048825557069031,0.062726239073513,0.807048100662784
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1289.Cooked vegetable intake,51266,-0.0692581201832118,0.0196871112261459,-0.107844858186458,-0.0306713821799658,0.000435781095814665
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50482,-0.0598887173215488,0.0205972032231568,-0.100259235638936,-0.0195181990041614,0.00364573561010921
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1309.Fresh fruit intake,51186,-0.0194442560105296,0.0201624667099307,-0.0589626907619938,0.0200741787409346,0.334866637534895
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1319.Dried fruit intake,50015,-0.0263491630080801,0.0201944877294982,-0.0659303589578965,0.0132320329417363,0.19198557755361
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X134.Number of self-reported cancers,51911,0.0240636646916001,0.0314649911418031,-0.037607717946334,0.0857350473295341,0.444412988365814
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X135.Number of self-reported non-cancer illnesses,51912,0.0838694824053201,0.0202514428588373,0.0441766544019991,0.123562310408641,3.46427524880809e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X136.Number of operations, self-reported",51912,0.00425353077587691,0.0195118144743327,-0.0339896255938152,0.042496687145569,0.82743285761378
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X137.Number of treatments or medications taken,51912,0.0517633028163104,0.0194813500194625,0.0135798567781639,0.0899467488544568,0.00788782839850455
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1438.Bread intake,51298,0.0143300535992877,0.00477391458791641,0.00497318100697155,0.0236869261916039,0.00268740504975401
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1458.Cereal intake,50950,0.0224182486939947,0.0193058977282528,-0.0154213108533808,0.0602578082413702,0.245568256007811
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1488.Tea intake,51222,0.00520389144084665,0.00464227558505232,-0.00389496870585591,0.0143027515875492,0.262309205367828
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1498.Coffee intake,50245,-0.0864852115284899,0.0194923685684675,-0.124690253922686,-0.0482801691342936,9.17369643066054e-06
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1528.Water intake,50071,-0.000507732404636904,0.0195171046224417,-0.0387612574646226,0.0377457926553488,0.979245830169642
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1568.Average weekly red wine intake,44709,-0.116969606846022,0.0226872310369149,-0.161436579678375,-0.0725026340136688,2.55727980981293e-07
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44708,-0.086511803820482,0.0231931604385468,-0.131970398280034,-0.0410532093609303,0.000192118627608884
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1588.Average weekly beer plus cider intake,44756,0.0569971519988563,0.025995959133011,0.00604507209815473,0.107949231899558,0.0283553705230294
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1598.Average weekly spirits intake,44692,-0.0127979736580442,0.0244086651417486,-0.0606389573358714,0.035043010019783,0.600062850839989
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1608.Average weekly fortified wine intake,44740,-0.0538140340567602,0.0366899416863056,-0.125726319761919,0.0180982516483987,0.142471261476717
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1737.Childhood sunburn occasions,45692,-0.0268023268705641,0.0236519430777049,-0.0731601353028656,0.0195554815617375,0.2571477192624
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1807.Father's age at death,49821,-0.00569937958827331,0.004506572480343,-0.0145322616497456,0.00313350247319896,0.205999753593085
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1845.Mother's age,32526,-0.0366360805180901,0.0211336896375147,-0.078058112207619,0.00478595117143871,0.0830923725584331
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1873.Number of full brothers,51501,0.0349516156405396,0.0187114673117621,-0.00172286029051408,0.0716260915715933,0.061785641789234
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1883.Number of full sisters,51507,0.0123829581377513,0.0187336038772307,-0.0243349054616209,0.0491008217371235,0.508617564644886
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20015.Sitting height,51750,0.0219689732143406,0.00599214603144301,0.0102243669927123,0.0337135794359689,0.000246655205452513
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20016.Fluid intelligence score,36618,-0.0471453510911855,0.0299709748713454,-0.105888461839023,0.0115977596566515,0.115753715369201
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20018.Prospective memory result,36975,0.0630645295959416,0.0376780992261398,-0.0107845448872924,0.136913604079176,0.0942157090505607
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36497,0.00762358320068712,0.00814961291702482,-0.00834965811668152,0.0235968245180558,0.349585612831624
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36481,-0.00267899230095704,0.00821353249899793,-0.018777515998993,0.0134195313970789,0.744306540553963
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20023.Mean time to correctly identify matches,51615,0.0143373294095279,0.00487453671882327,0.00478323744063426,0.0238914213784215,0.00327203425830384
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#1.Illnesses of father_Heart disease,48535,-0.0196349506287153,0.0101851665227986,-0.0395978770134006,0.000327975755969896,0.0538947956138513
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48090,0.00214671591452107,0.0216257623171466,-0.0402397782270862,0.0445332100561283,0.920927649124027
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48058,-0.00943540018023545,0.0288820357054192,-0.066044190162857,0.0471733898023861,0.743907876275115
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#12.Illnesses of father_Severe depression,48066,-0.0171980510670525,0.0276922410705059,-0.0714748435652441,0.0370787414311391,0.534579340405593
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48089,-0.0428603107225408,0.0191388886908398,-0.0803725325565868,-0.00534808888849475,0.0251391661873109
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#2.Illnesses of father_Stroke,48261,-0.0054973282777803,0.012777076058212,-0.0305403973518759,0.0195457407963153,0.667019151914934
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48207,0.0189758849768175,0.0156259562962071,-0.0116509893637484,0.0496027593173833,0.224616848093914
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48105,0.0281587198246108,0.0203146976482853,-0.0116580875660283,0.0679755272152499,0.165724937251629
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48254,0.0216049618897912,0.0138172617377062,-0.00547687111611298,0.0486867948956953,0.117923180399284
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48245,-0.00261489439620611,0.0128253534369802,-0.0277525871326872,0.022522798340275,0.838445714836374
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#9.Illnesses of father_Diabetes,48129,0.0291706716160244,0.0182393675660882,-0.00657848881350848,0.0649198320455572,0.109765151527746
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49628,0.000584133726925124,0.0110330240912537,-0.0210405934919322,0.0222088609457824,0.957776950310278
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49474,-0.0156261435180166,0.0143685675490695,-0.0437885359141929,0.0125362488781596,0.276818792340846
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49384,0.0255897429023498,0.0318704876528107,-0.0368764128971591,0.0880558987018588,0.42202515004581
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49409,-0.0158841092608884,0.0199059274764067,-0.0548997271146456,0.0231315085928689,0.424903794234707
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#2.Illnesses of mother_Stroke,49562,-0.000719526794314398,0.0120674316804456,-0.0243716928879879,0.0229326392993591,0.952454483720182
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49430,0.0106067669840071,0.0231495315452102,-0.0347663148446049,0.0559798488126192,0.646824490542367
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49413,0.0100474225004102,0.0195987229181655,-0.0283660744191941,0.0484609194200146,0.608196873717781
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49417,-0.0177127892376353,0.0172714618483007,-0.0515648544603047,0.0161392759850341,0.305114878325599
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49464,0.014529050830615,0.0193386311963121,-0.0233746663141567,0.0524327679753867,0.452482804937647
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49609,0.00992433788242364,0.0107274466787502,-0.0111014576079268,0.030950133372774,0.354906551738408
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49476,0.0169129933505194,0.0164545634158882,-0.0153379509446214,0.0491639376456603,0.304027779650197
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45869,-0.00409717337589098,0.0139755158433471,-0.0314891844288514,0.0232948376770694,0.769397426160007
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45699,0.0404971852822133,0.0487292798547813,-0.0550122032331581,0.136006573797585,0.405949091125556
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45689,0.0456298652186433,0.0523595482852844,-0.0569948494205142,0.148254579857801,0.383509328114628
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45721,0.00945323630504216,0.0212863757282647,-0.0322680601223566,0.0511745327324409,0.656977566663092
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45714,-0.0179079713154198,0.029276982821508,-0.0752908576455754,0.0394749150147358,0.540761836598199
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45751,0.027924404337155,0.0232209143218647,-0.0175885877336999,0.0734373964080098,0.229166138964709
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45712,-0.00963359149320604,0.025859210794333,-0.0603176446500987,0.0410504616636867,0.709495583882118
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45707,0.0129648045521666,0.026294673801548,-0.0385727560988674,0.0645023652032007,0.621978020786514
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45727,0.0033831105569692,0.0213651135482113,-0.038492511997525,0.0452587331114634,0.874184979550698
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45742,-0.000923184956524412,0.0252005185429992,-0.0503162013008028,0.048469831387754,0.970777618487128
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45916,0.0127092259508774,0.0117558118021869,-0.010332165181409,0.0357506170831637,0.279667550378961
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45808,0.0458819506049154,0.016152409978386,0.0142232270472789,0.0775406741625519,0.00450886163019888
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20127.Neuroticism score,47020,0.00433790361397917,0.0196579653795326,-0.0341917085299048,0.0428675157578631,0.825352697567448
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36618,0.0142363484144378,0.0304693616885554,-0.0454836004951307,0.0739562973240064,0.640345577309576
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20161.Pack years of smoking,36882,0.0223458664569651,0.00785623558603926,0.00694764470832816,0.0377440882056021,0.00446199473965314
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36882,0.0225976313687926,0.00811560218285324,0.00669105109040023,0.0385042116471849,0.00537467682024244
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20191.Fluid intelligence score,34228,-0.0250883940873162,0.0385673320670799,-0.100680364938793,0.0505035767641605,0.515393290697965
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34229,-0.0315859521533579,0.0395138617468849,-0.109033121177252,0.0458612168705365,0.424117270459073
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20240.Maximum digits remembered correctly,33596,-0.0215981926236539,0.0410683715221147,-0.102092200806999,0.058895815559691,0.598978543631701
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20255.Spirometry QC measure,45971,-0.00641527756863132,0.024688597783544,-0.0548049292243775,0.0419743740871149,0.794984373952426
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20261.avMSE,34245,-0.000943240139758603,0.00910301458735827,-0.0187851487309808,0.0168986684514636,0.917476269869888
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20262.Myopia diagnosis,34245,0.0257965546806944,0.0485478466981888,-0.0693572248477556,0.120950334209144,0.595190266417516
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20280.Glucose-lactate,42339,0.0207389008097624,0.00596132056057528,0.00905471251103489,0.03242308910849,0.00050508700254728
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20281.Spectrometer-corrected alanine,42364,0.022213122803743,0.00610836271325381,0.0102407318857655,0.0341855137217205,0.000277411065537101
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36318,-0.0442523866955447,0.037404939029794,-0.117566067193941,0.0290612938028515,0.236823793635408
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36318,-0.00676747672627766,0.0697406472724279,-0.143459145380236,0.129924191927681,0.922699131408201
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36318,0.0180113799809132,0.116378250476129,-0.210089990952299,0.246112750914125,0.877010291219427
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36318,-0.05216356888153,0.0344797280873119,-0.119743835932661,0.0154166981696014,0.130355401760716
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36318,-0.00450781769435779,0.0715483048556271,-0.144742495211387,0.135726859822671,0.949765216940845
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36321,-0.213163364064454,0.0894161958002936,-0.38841910783303,-0.0379076202958787,0.0171541430436498
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36321,-0.0607501861846171,0.0562400012039507,-0.17098058854436,0.0494802161751262,0.280091763262109
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36321,-0.104484963131554,0.0678743118825944,-0.237518614421439,0.028548688158331,0.123753773543619
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36321,-0.191686594813333,0.105636926092138,-0.398734969953923,0.0153617803272572,0.0696305864691412
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36321,-0.338488629200576,0.121897088302309,-0.577406922273101,-0.0995703361280506,0.0055033677050284
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36321,-0.159967961353279,0.074593737911471,-0.306171687659762,-0.0137642350467959,0.0320247456971079
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36321,-0.199444187476187,0.12399332358275,-0.442471101698377,0.043582726746003,0.10776837368995
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36321,-0.205621488069229,0.0871653573573193,-0.376465588489575,-0.0347773876488835,0.0183519878805187
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36320,0.0909535213323165,0.118070739607221,-0.140465128297838,0.322372170962471,0.441129257513989
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36320,0.00682135411113672,0.0469748579837528,-0.0852493675370188,0.0988920757592923,0.884546908979765
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36320,-0.0560340439594943,0.086485934809921,-0.225546476186939,0.113478388267951,0.517071949249156
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36322,-0.103573739386268,0.153292256846107,-0.404026562804639,0.196879084032102,0.499277242039348
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20600.Liking for adding salt to foods,36110,-0.0568379348500997,0.0325850992299511,-0.120704729340804,0.00702885964060447,0.0811526307807806
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20601.Liking for aniseed,36110,-0.0532259935429947,0.0319121637321029,-0.115773834457916,0.00932184737192695,0.0953828032562762
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20602.Liking for apple juice,36110,-0.0177867079492536,0.032218605730323,-0.0809351751806867,0.0453617592821794,0.580922886264508
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20603.Liking for apples,36110,-0.00485027769966853,0.0333824821115663,-0.0702799426383384,0.0605793872390013,0.884482912229665
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20604.Liking for asparagus,36110,-0.0743314717754249,0.0325317132252421,-0.138093629696899,-0.0105693138539505,0.022349304176389
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20605.Liking for aubergine,36110,-0.0611821243245665,0.0322805558076766,-0.124452013707613,0.00208776505847955,0.0580911532181156
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20606.Liking for avocados,36110,-0.0667722954019601,0.0325597044873836,-0.130589316197232,-0.00295527460668815,0.0403275093401387
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20607.Liking for bacon,36110,0.0524201011427305,0.0329030519062897,-0.0120698805935973,0.116910082879058,0.11116818550737
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20608.Liking for baked or steamed fish,36110,-0.0934701594896866,0.0331320388310681,-0.15840895559858,-0.0285313633807932,0.00479896975246392
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20609.Liking for bananas,36110,0.0624488105425237,0.0334447412158399,-0.00310288224052255,0.12800050332557,0.0619126946695288
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36110,0.00712157284356811,0.0326104085418428,-0.0567948278984438,0.07103797358558,0.827136827364412
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20611.Liking for beef steak,36110,0.0136384468909861,0.0326440796924611,-0.0503439493062376,0.0776208430882099,0.676111928876906
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20612.Liking for beetroot,36110,0.0439495092189572,0.033055455646329,-0.0208391838478476,0.108738202285762,0.18370422516348
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20613.Liking for bell pepper,36110,-0.0793082858882263,0.0321665467461236,-0.142354717510629,-0.0162618542658241,0.0137043726288546
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20614.Liking for bicycling,36110,-0.0772593424963534,0.0324817403297763,-0.140923553542715,-0.0135951314499919,0.0174080543933832
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20615.Liking for biscuits,36110,0.0565070991923456,0.0322364606417809,-0.00667636366554487,0.119690562050236,0.0796645614771892
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20616.Liking for bitter foods,36110,-0.0853423341116631,0.0322518712846986,-0.148556001829672,-0.0221286663936539,0.00816054010347635
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20617.Liking for bitter or ale,36110,-0.0466984447361799,0.0329322495273089,-0.111245653809705,0.0178487643373455,0.156231312969715
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20618.Liking for black olives,36110,-0.0737817662599824,0.0323594851568764,-0.13720635716746,-0.0103571753525046,0.0226341081213421
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20619.Liking for black pepper,36110,-0.0540407042522399,0.0327331103316987,-0.118197600502369,0.0101161919978894,0.0987943989216097
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20620.Liking for blue cheese,36110,-0.124342870456091,0.032529833159398,-0.188101343448511,-0.0605843974636709,0.000133306587444771
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20621.Liking for bolognese sauce,36110,-0.0308741223932407,0.0323621127688124,-0.094303863420113,0.0325556186336317,0.340106598631427
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20622.Liking for broad beans,36110,-0.0581552410318434,0.0323601001114399,-0.121581037250266,0.00527055518657885,0.0723589746788187
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20623.Liking for broccoli,36110,-0.0551211457131869,0.0333259048035299,-0.120439919128106,0.0101976277017318,0.0981723483973887
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20624.Liking for brown rice,36110,-0.0213506136992378,0.0323727081773908,-0.0848011217269239,0.0420998943284482,0.509580620307733
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20625.Liking for brussel sprouts,36110,-0.0578501028144636,0.0329511713819214,-0.122434398723029,0.0067341930941022,0.0791957327970401
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20626.Liking for burgers (meat),36110,0.018858147077578,0.0321613179525068,-0.0441780361093353,0.0818943302644914,0.557652013582637
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20627.Liking for burn of spicy foods,36110,-0.0715850657162804,0.0321364028928397,-0.134572415386246,-0.00859771604631461,0.0259434170968888
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20628.Liking for butter on bread,36110,-0.00111665017671923,0.0326629377942594,-0.0651360082534677,0.0629027079000292,0.972728964149077
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20629.Liking for butternut squash,36110,-0.0447226174217094,0.0324431914901332,-0.10831127274237,0.0188660378989516,0.168096676397282
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20630.Liking for cabbage,36110,-0.0294888081206643,0.0328114107976401,-0.0937991732840389,0.0348215570427103,0.368824430438787
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20631.Liking for cake,36110,0.0749286702546378,0.0323956304027029,0.0114332346653402,0.138424105843935,0.020755988891434
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20632.Liking for cake icing,36110,0.00187969277573192,0.0322384155017188,-0.0613076016076369,0.0650669871591007,0.953506581896259
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20633.Liking for capers,36110,-0.0572519943691812,0.0321224320879678,-0.120211961261598,0.00570797252323563,0.0747433053952581
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20634.Liking for cauliflower,36110,-0.0741911517905705,0.0334758737435288,-0.139803864327887,-0.00857843925325408,0.0267063462053116
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20635.Liking for cereal or granola bar,36110,0.0388612933097983,0.0321588879566725,-0.0241701270852799,0.101892713704876,0.226928914156127
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20636.Liking for cheesecake,36110,-0.0125111944482402,0.0321780684865568,-0.0755802086818915,0.050557819785411,0.697427776382601
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20637.Liking for cherries,36110,-0.0186436108313551,0.0345270155165995,-0.08631656124389,0.0490293395811798,0.589233966205523
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20638.Liking for chicken,36110,0.03854394899077,0.0341817078626746,-0.0284521984200723,0.105540096401612,0.259519957210569
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20639.Liking for chilli pepper,36110,-0.0593499222052629,0.032270183407774,-0.1225994816845,0.00389963727397406,0.0659350479859826
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20640.Liking for chips or french fries,36110,0.0680099364514469,0.0324808578687123,0.00434745502877081,0.131672417874123,0.0363100054301944
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20641.Liking for cigarette smoking,36110,-0.0551645612572069,0.0547496922745303,-0.162473958115286,0.0521448356008724,0.313692602861837
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20642.Liking for cod,36110,-0.0332608303535249,0.0336337608582063,-0.0991830016356093,0.0326613409285595,0.322740830450032
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20643.Liking for coffee with sugar,36110,0.021798504630233,0.0351568492298305,-0.0471089198602348,0.0907059291207009,0.535254681726273
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20644.Liking for coffee without sugar,36110,-0.0606813690032521,0.0334187463496554,-0.126182111848577,0.00481937384207245,0.0694461904823224
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20645.Liking for coriander,36110,-0.0684397007013172,0.0321221794748524,-0.131399172472028,-0.00548022893060648,0.0331568617157926
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20646.Liking for corn flakes,36110,0.0080010483717993,0.0322299085407921,-0.0551695723681532,0.0711716691117518,0.80394899679293
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20647.Liking for cream,36110,-0.0159386879910982,0.0323342281754905,-0.0793137752150595,0.0474363992328631,0.622073853351272
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20648.Liking for croissant,36110,-0.106544286180048,0.0320286946532918,-0.1693205277005,-0.0437680446595965,0.000883949201554396
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20649.Liking for cucumber,36110,-0.0227219163849663,0.0327616600272724,-0.0869347700384202,0.0414909372684877,0.487986496949597
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20650.Liking for curry,36110,-0.0383702040421235,0.03244240263103,-0.101957313198942,0.0252169051146953,0.236961754396003
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20651.Liking for dairy products,36110,0.0294053262556256,0.0326512022717717,-0.034591030197047,0.0934016827082982,0.367838078272167
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20652.Liking for dark chocolate,36110,-0.0489950982893492,0.0328046898978254,-0.113292290489087,0.0153020939103885,0.13534171515211
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20653.Liking for diet fizzy drinks,36110,0.0323483825998493,0.0336755885474888,-0.0336557709532286,0.0983525361529273,0.336792745559411
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20654.Liking for dried fruit,36110,-0.0629516961790655,0.0327436957919695,-0.127129339931326,0.00122594757319469,0.0545765004383117
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20655.Liking for eggs,36110,0.0217892877562959,0.0336445817796831,-0.0441540925318831,0.0877326680444749,0.517244905207047
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20656.Liking for exercising alone,36110,-0.0760579229044336,0.0323088511260388,-0.13938327111147,-0.0127325746973977,0.0185959973319687
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20657.Liking for exercising with others,36110,-0.0214287447679315,0.0322325017582672,-0.0846044482141351,0.0417469586782722,0.506189155208401
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20658.Liking for extra virgin olive oil,36110,-0.053175005746665,0.0326231395956562,-0.117116359354151,0.0107663478608211,0.103151706585279
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20659.Liking for fatty foods,36110,-0.0205687122055206,0.032343678724577,-0.0839623225056916,0.0428248980946504,0.524835126150709
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20660.Liking for fresh tomatoes,36110,-0.0408385178565372,0.0348886478758127,-0.10922026769313,0.0275432319800558,0.241824572405901
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20661.Liking for fried chicken,36110,0.0136737680466605,0.0320745788421231,-0.0491924064839009,0.0765399425772218,0.669894022909048
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20662.Liking for fried or battered fish,36110,0.0196293709478373,0.0325808606001295,-0.0442291158284165,0.083487857724091,0.546873346708944
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20663.Liking for fruit,36110,-0.0035955798012148,0.036964893413818,-0.0760467708922981,0.0688556112898685,0.922514702569462
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20664.Liking for garlic,36110,-0.0822851716049387,0.0326003935547148,-0.14618194297218,-0.0183884002376976,0.0116232234843091
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20665.Liking for gherkins,36110,-0.0763028158430042,0.0322792315704367,-0.13957010972106,-0.0130355219649483,0.0181143307124131
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20666.Liking for globe artichoke,36110,-0.0871486036825734,0.0324501069241422,-0.150750813253892,-0.0235463941112547,0.00725687680248844
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20667.Liking for goat's cheese,36110,-0.0435796898549381,0.0319507941245103,-0.106203246338978,0.0190438666291021,0.172623765922111
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20668.Liking for going to a cafe,36110,-0.0278673186411819,0.0324872506735362,-0.0915423299613129,0.0358076926789491,0.391036837874818
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20669.Liking for going to the gym,36110,-0.0574139896992157,0.031952503256032,-0.120040896081038,0.00521291668260712,0.072402442214799
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20670.Liking for going to the pub,36110,-0.047515093894357,0.0322073406392843,-0.110641481547354,0.0156112937586402,0.140180789543099
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20671.Liking for grapefruit,36110,-0.016457300302106,0.0322381977354261,-0.0796441678635412,0.0467295672593292,0.609724038491709
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20672.Liking for green olives,36110,-0.0525747220122403,0.0325521200285087,-0.116376877268117,0.0112274332436368,0.106336092905417
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20673.Liking for haddock,36110,-0.0450121659958791,0.0335319016485276,-0.110734693226993,0.0207103612352349,0.179520685603016
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20674.Liking for ham,36110,0.0540522092087429,0.0326836039048347,-0.0100076544447331,0.118112072862219,0.0982131931218194
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20675.Liking for hard cheese,36110,-0.0451810479394975,0.0329120267962456,-0.109688620460139,0.0193265245811439,0.169864602788612
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20676.Liking for herring,36110,-0.0500041641864272,0.0320467622475102,-0.112815818191547,0.0128074898186928,0.118723017707666
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20677.Liking for honey,36110,-0.00642417438921406,0.0324394239317253,-0.0700054452953957,0.0571570965169676,0.843022710289372
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20678.Liking for horseradish or wasabi,36110,-0.0779090704678059,0.0322168586687927,-0.141054113458639,-0.0147640274769723,0.0156201887505967
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20679.Liking for ice cream,36110,0.00962257504133406,0.0323154838339139,-0.0537157732731371,0.0729609233558052,0.765887824185648
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20680.Liking for jam,36110,0.0245096423402668,0.0324087019518994,-0.039011413485456,0.0880306981659897,0.449514726928557
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20681.Liking for kiwi fruit,36110,-0.00373867884873836,0.0323365545812601,-0.0671183258280082,0.0596409681305315,0.907958876264563
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20682.Liking for lager,36110,0.0201484001960352,0.0323294623909225,-0.0432173460901728,0.0835141464822433,0.533159874846739
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20683.Liking for lamb,36110,-0.00926479900492359,0.0331814190280586,-0.0743003802999185,0.0557707822900713,0.780087057410867
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20684.Liking for lemons,36110,-0.0456943280783534,0.0323283086160401,-0.109057812965792,0.0176691568090852,0.157569606225123
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20685.Liking for lentils or beans,36110,0.00991397339367027,0.0324800330949041,-0.0537468914723418,0.0735748382596823,0.760198004634773
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20686.Liking for liver,36110,-0.0524463726537237,0.0327020198886263,-0.116542331635431,0.0116495863279839,0.108811464705571
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20687.Liking for mackerel,36110,-0.0510665792402127,0.0325879809743777,-0.114939021949993,0.0128058634695675,0.11715180062364
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20688.Liking for marzipan,36110,-0.0214443814815996,0.0322212960598131,-0.0845981217588334,0.0417093587956341,0.505730961551508
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20689.Liking for mayonnaise,36110,-0.0206209885031138,0.0322745751187156,-0.0838791557357964,0.0426371787295688,0.522893804983935
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20690.Liking for melon,36110,0.0295683302216502,0.0334204261447751,-0.0359357050221091,0.0950723654654095,0.376328603594306
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20691.Liking for milk chocolate,36110,0.0429270554259984,0.0322623241847364,-0.0203070999760849,0.106161210828082,0.183376763311821
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20692.Liking for mushrooms,36110,-0.063592417722916,0.0333819029360183,-0.129020947477512,0.00183611203167976,0.0568219807994113
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20694.Liking for orange juice,36110,0.00150086943942365,0.0324111163673177,-0.062024918640519,0.0650266575193663,0.963066705216744
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20695.Liking for oranges,36110,0.0296279901591676,0.033012580478605,-0.0350766675788983,0.0943326478972335,0.369496393193327
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20696.Liking for pasta,36110,-0.0504413849419591,0.0328894245276334,-0.114904657016121,0.0140218871322024,0.125157697022567
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20697.Liking for pears,36110,0.0236330617896156,0.0331689599919394,-0.0413780997945856,0.0886442233738169,0.476175960964409
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20698.Liking for pizza,36110,0.0232459214902235,0.0325036534043107,-0.0404612391822256,0.0869530821626725,0.474522784614165
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20699.Liking for plain yogurt,36110,-0.0396136599409735,0.0326671210575155,-0.103641217213704,0.0244138973317569,0.225306594594905
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20700.Liking for plums,36110,-0.0250816694030813,0.0329810901662479,-0.0897246061289272,0.0395612673227647,0.446989874753338
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20701.Liking for pollock,36110,-0.00788972503566353,0.0320437861279098,-0.0706955458463667,0.0549160957750396,0.805521569326192
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20702.Liking for pork chop,36110,0.0282679241636523,0.0329042515193808,-0.0362244088143342,0.0927602571416387,0.390317144641249
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20703.Liking for porridge,36110,-0.0114610253163687,0.0332124450315276,-0.0765574175781628,0.0536353669454254,0.730043043651788
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20704.Liking for potato crisps,36110,0.0467330395414242,0.0325784173925524,-0.0171206585479785,0.110586737630827,0.151481031227705
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20705.Liking for potatoes,36110,0.0659482733779778,0.0327553139575784,0.00174785802112408,0.130148688734831,0.0441153723307778
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20706.Liking for prawns,36110,-0.0211033814341037,0.0326620138094173,-0.0851209285005617,0.0429141656323542,0.51822705383708
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20707.Liking for raw carrots,36110,-0.0247001373482895,0.0326589106365124,-0.0887116021958539,0.0393113274992748,0.449491412037412
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20708.Liking for red meat,36110,-0.00765781368627836,0.0327144483964113,-0.0717781325432444,0.0564625051706877,0.81492943972829
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20709.Liking for red wine,36110,-0.0635613869586326,0.0324594420506726,-0.127181893377951,5.91194606856527e-05,0.0502492464573942
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36110,0.018469949653118,0.0333828048486557,-0.0469603478502472,0.0839002471564832,0.580091418721661
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20711.Liking for roast chicken,36110,0.0167903710387076,0.0342709399536479,-0.0503806712704422,0.0839614133478574,0.624198799337949
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20712.Liking for salad dressing,36110,0.00480458700488391,0.0323215056669973,-0.0585455641024309,0.0681547381121987,0.881834273985068
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20713.Liking for salad leaves,36110,0.0110758325077825,0.0329087661101081,-0.0534253490680294,0.0755770140835944,0.736457505717989
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20714.Liking for salami,36110,-0.026966280317476,0.0320209528142977,-0.0897273478334995,0.0357947871985475,0.399736040437766
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20715.Liking for salmon,36110,-0.0689229534100783,0.0340468862699846,-0.135654850499248,-0.00219105632090849,0.0429721417127828
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20716.Liking for salty foods,36110,-0.00465601719722689,0.0321049145065998,-0.0675816496301624,0.0582696152357087,0.884695316374427
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20717.Liking for salty pretzels,36110,-0.0119323892230754,0.0322261092272603,-0.0750955633085055,0.0512307848623547,0.71119203608301
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20718.Liking for sardines,36110,-0.0698221290671262,0.0322932487697902,-0.133116896655915,-0.00652736147833734,0.0306425576071297
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20719.Liking for sausages (meat),36110,0.0119918893493991,0.0324527712446184,-0.0516155422900531,0.0755993209888512,0.711752844064002
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20720.Liking for savoury biscuits,36110,-0.0223776371574336,0.0325599543360091,-0.0861951476560115,0.0414398733411442,0.491932630916067
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36110,-0.079887764159144,0.0320855640022211,-0.142775469603497,-0.0170000587147906,0.0128035737642305
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20722.Liking for skimmed milk,36110,-0.0371591756530339,0.032395093034402,-0.100653558000462,0.0263352066943941,0.251395787718841
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20723.Liking for smoked fish,36110,-0.0748649845610175,0.032668864450056,-0.138895958883127,-0.0108340102389076,0.0219568950405532
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20724.Liking for soft cheese,36110,-0.0875834258175374,0.0322343394456535,-0.150762731131018,-0.0244041205040565,0.00660239203201301
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20725.Liking for soy sauce,36110,-0.007012690074109,0.0324538052787268,-0.0706221484204136,0.0565967682721956,0.828930044843654
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20726.Liking for soya milk,36110,-0.00221259805362603,0.0323544537186179,-0.0656273273421171,0.061202131234865,0.945480188642435
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20727.Liking for spicy foods,36110,-0.0541217765718562,0.0322138037220691,-0.117260831867112,0.00901727872339923,0.0929869178598291
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20728.Liking for spinach,36110,-0.0418616952397582,0.0326043482350507,-0.105766217780458,0.0220428273009412,0.19920957669509
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20729.Liking for spirits,36110,-0.020912657509353,0.0322190584316523,-0.0840620120353916,0.0422366970166856,0.516310033816194
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20730.Liking for strawberries,36110,0.0528160854932562,0.035267565849742,-0.0163083435722382,0.121940514558751,0.134287480999965
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36110,0.0140473835831103,0.0330099735199418,-0.0506521645159755,0.0787469316821962,0.670449274084247
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20732.Liking for sweet foods,36110,0.00195849811601596,0.0322973353774598,-0.0613442792238052,0.0652612754558372,0.951647974492059
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20733.Liking for taking the stairs,36110,-0.0279215089318198,0.0327902141598674,-0.0921903286851599,0.0363473108215204,0.394510320194708
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20734.Liking for tea with sugar,36110,0.00278988552841292,0.0395774534950053,-0.0747819233217975,0.0803616943786234,0.943804275944222
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20735.Liking for tea without sugar,36110,-0.0077706285373303,0.0341070681364764,-0.0746204820848241,0.0590792250101635,0.819784800486637
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20736.Liking for tomato ketchup,36110,0.0400484162421311,0.0322253730790369,-0.0231133149927812,0.103210147477043,0.213998341235096
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20737.Liking for tinned tuna,36110,0.00664736445847646,0.032629622297415,-0.0573066952444569,0.0706014241614098,0.838576929372604
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20738.Liking for turnip (white),36110,-0.0288456746717383,0.0323036648705388,-0.0921608578179943,0.0344695084745178,0.371913117234585
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20739.Liking for vegetables,36110,-0.0218843500826672,0.035679684588094,-0.0918165318753316,0.0480478317099971,0.53966114253781
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20740.Liking for vinegar,36110,0.0240997860142484,0.032113453751436,-0.0388425833385662,0.087042155367063,0.45300470363798
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20741.Liking for watching television,36110,0.0943794236621594,0.0328121149483264,0.0300676783634396,0.158691168960879,0.00403523371833938
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20742.Liking for whisky,36110,-0.0024649921516658,0.0332836279450164,-0.067700902923898,0.0627709186205664,0.940964628457559
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20743.Liking for white bread,36110,0.00503298133144054,0.0320693696753504,-0.0578229832322462,0.0678889458951273,0.875296366859227
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20744.Liking for white rice,36110,0.00144403134441521,0.032749192406135,-0.0627443857716094,0.0656324484604398,0.964831031075826
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20745.Liking for white wine,36110,-0.0231400753649116,0.0323838948379157,-0.0866125092472263,0.0403323585174031,0.474908181178704
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36110,-0.0302899402783979,0.0327947252754031,-0.0945676018181879,0.0339877212613922,0.355715252378721
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20747.Liking for whole milk,36110,0.0233620394834456,0.0319906682949016,-0.0393396703745615,0.0860637493414527,0.465245838963219
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20748.Liking for wholemeal bread,36110,-0.00366660287688648,0.034103585356178,-0.0705096301749953,0.0631764244212224,0.914384574577631
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20749.Liking for working up a sweat,36110,-0.0536831103744543,0.03279727396218,-0.117965767340327,0.0105995465914185,0.101714430648144
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21001.Body mass index (BMI),51806,-0.131731296865192,0.0210605529064046,-0.173009980561745,-0.0904526131686392,4.04941490884979e-10
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21002.Weight,51825,0.0116208830744701,0.0113044090701079,-0.0105357587029413,0.0337775248518816,0.303962872235584
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21021.Pulse wave Arterial Stiffness index,36934,0.0178717067554087,0.00766051570602717,0.00285709597159543,0.0328863175392219,0.0196755269007165
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35913,-0.0110345039660136,0.0349944708624202,-0.0796236668563572,0.0575546589243299,0.752527472412541
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35930,-0.000218092759586634,0.0355709873237212,-0.0699372279140802,0.0695010423949069,0.995108224219675
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35932,-0.0292120292018124,0.0352924714952127,-0.0983852733324293,0.0399612149288046,0.407862514559004
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21040.Satisfaction with bowel habits,35885,0.0554704785157527,0.0324645952934529,-0.00816012825941491,0.11910108529092,0.0875631105629386
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35870,0.0441912060737707,0.0349977644171434,-0.0244044121838304,0.112786824331372,0.206746014776887
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21042.Greatest number of times bowels opened per day,35890,0.0408562141969406,0.0348860482573338,-0.0275204403874336,0.109232868781315,0.241586864167872
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21043.Least number of times bowels opened per week,35823,0.0281381885455706,0.0349141638322633,-0.0402935725656655,0.0965699496568067,0.420315156009832
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21044.Average number of times bowels opened per day,35853,0.0235460140671413,0.0397037208098935,-0.0542732787202499,0.101365306854532,0.553172533269154
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35936,0.0288871055768089,0.0353288627461397,-0.0403574654056249,0.0981316765592428,0.413578515123506
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35931,0.0317579402368774,0.0357090563190514,-0.0382318101484633,0.101747690622218,0.373845397585815
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32720,-0.0734364073158411,0.062896436052981,-0.196713421979684,0.0498406073480017,0.243056560437908
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35934,0.072257928784036,0.0407973455276549,-0.00770486845016763,0.15222072601824,0.0765821319660672
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35933,-0.0280336457443257,0.0535019591461825,-0.132897485670843,0.076830194182192,0.600313725226457
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35931,0.0527388409786913,0.0409270128085136,-0.0274781041259953,0.132955786083378,0.197578955373196
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35932,-0.135029271703035,0.103528625436355,-0.33794537755829,0.0678868341522205,0.192186125372977
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35937,0.0341580179607727,0.0417824808406813,-0.0477356444869627,0.116051680408508,0.413660155804365
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35933,-0.0748241377774568,0.0387658010199733,-0.150805107776604,0.0011568322216909,0.0536291305989179
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35779,0.0065308979641692,0.0368913093030279,-0.0657760682697655,0.0788378641981039,0.85948964368716
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35928,-0.0192604919064851,0.0354157492815008,-0.0886753604982266,0.0501543766852565,0.586569765543511
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35933,0.00631544632751937,0.056590015990149,-0.104600985013173,0.117231877668211,0.911143888531127
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35938,-0.0661848471541043,0.0359139093037733,-0.1365761093895,0.00420641508129131,0.0653911237432454
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35937,-0.0142345978143885,0.0352500341258429,-0.0833246647010406,0.0548554690722637,0.68635937624202
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X21100.Water hardness (USGS classification),51773,-0.030264123478049,0.0187285217845732,-0.0669720261758125,0.00644377921971448,0.106121766692809
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2139.Age first had sexual intercourse,48030,-0.0105098568756657,0.00516349037712981,-0.0206302980148402,-0.000389415736491313,0.0418228852825675
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2149.Lifetime number of sexual partners,46862,-0.0324092772051142,0.0214571509040219,-0.0744652929769971,0.00964673856676866,0.130954560976641
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22032.IPAQ activity group,46863,-0.0582414022733316,0.0213998863262024,-0.100185179472688,-0.0162976250739749,0.0065035236108738
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22033.Summed days activity,47365,-0.0129988236664248,0.00505207391355127,-0.0229008885369853,-0.00309675879586433,0.0100909178101416
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22034.Summed minutes activity,46863,-0.0155242718205321,0.00500046414170494,-0.0253251815382737,-0.00572336210279036,0.00190859456327909
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22037.MET minutes per week for walking,45886,-0.0108716793219031,0.00536411687115774,-0.0213853483893723,-0.000358010254433929,0.0427047008118705
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22038.MET minutes per week for moderate activity,46863,-0.0121374389492815,0.00487948418200258,-0.0217012279460066,-0.00257364995255646,0.01287565690001
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22039.MET minutes per week for vigorous activity,46863,-0.0675171350349464,0.0213566899001746,-0.109376247239289,-0.0256580228306042,0.00157275574318318
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22040.Summed MET minutes per week for all activity,45886,-0.0136232685314524,0.00521180828788934,-0.0238384127757155,-0.00340812428718925,0.00895894046387724
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X2217.Age started wearing glasses or contact lenses,49973,0.00337064946764282,0.00428447734498457,-0.00502692612852693,0.0117682250638126,0.431459487260689
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X22501.Year ended full time education,34043,-0.0349487318691729,0.0212559570583697,-0.0766104077035775,0.00671294396523169,0.10020275969132
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X22506.Tobacco smoking,34012,-0.0662726154487497,0.0833599298000073,-0.229658077856764,0.0971128469592645,0.426642413109448
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50619,-0.127604129122506,0.0687407332446102,-0.262335966281942,0.00712770803692994,0.0634230651669205
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23098.Weight,51340,0.0121574148888684,0.0114330511346411,-0.0102513653350282,0.034566195112765,0.287631682266183
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23099.Body fat percentage,51332,-0.00507809825824492,0.0108738605984872,-0.0263908650312797,0.0162346685147899,0.640504121463612
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23100.Whole body fat mass,51316,0.00787063339294528,0.0107223146013835,-0.0131451032257664,0.028886370011657,0.462930685218578
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23101.Whole body fat-free mass,51339,0.0160497438337974,0.00931547295878354,-0.00220858316541836,0.0343080708330131,0.0849183288284878
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23102.Whole body water mass,51340,0.0146797955188876,0.00934375493935259,-0.00363396416224346,0.0329935552000187,0.116178129709136
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23104.Body mass index (BMI),51340,-0.121863251724827,0.0210857715696581,-0.163191364001357,-0.0805351394482968,7.59701438994261e-09
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23105.Basal metabolic rate,51340,0.0143542664898183,0.0099531921542108,-0.0051539901324349,0.0338625231120714,0.149266540843608
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23106.Impedance of whole body,51338,0.0104161544711778,0.0076175857926288,-0.0045143136823746,0.0253466226247303,0.171519283464773
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23107.Impedance of leg (right),51340,-0.00573127195684273,0.0061431486065081,-0.0177718432255986,0.00630929931191315,0.35085415179597
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23108.Impedance of leg (left),51340,-0.00478773168801386,0.00609802555595322,-0.0167398617776822,0.00716439840165444,0.432386819604608
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23109.Impedance of arm (right),51337,0.0174724368966568,0.00749972254284037,0.00277298071268966,0.0321718930806239,0.0198286040808157
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23110.Impedance of arm (left),51340,0.0146293173534928,0.00752718033230567,-0.000123956097826288,0.0293825908048119,0.05196453994244
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23111.Leg fat percentage (right),51340,-0.0479604351882684,0.0127830747914455,-0.0730152617795015,-0.0229056085970353,0.000175967992839755
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23112.Leg fat mass (right),51340,-0.00222881586798693,0.0139939590241622,-0.0296569755553448,0.025199343819371,0.87345771975556
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23113.Leg fat-free mass (right),51339,0.0294972379801778,0.00947058427270606,0.0109348928056739,0.0480595831546817,0.00184419212444724
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23114.Leg predicted mass (right),51339,0.0309117435607259,0.0095275760711707,0.0122376944612314,0.0495857926602205,0.00117852219984065
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23115.Leg fat percentage (left),51337,-0.0488200811787456,0.0134293569092713,-0.0751416207209173,-0.022498541636574,0.000278258913826453
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23116.Leg fat mass (left),51337,-0.00317211999782946,0.0146527427195419,-0.0318914957281316,0.0255472557324727,0.828610593993241
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23117.Leg fat-free mass (left),51336,0.0316858274456901,0.00996418869378603,0.0121560176058695,0.0512156372855107,0.00147492847946104
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23118.Leg predicted mass (left),51336,0.0333107236889243,0.0100243381161745,0.0136630209812223,0.0529584263966263,0.000892040695143602
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23119.Arm fat percentage (right),51336,-0.0160655922421091,0.0122786001606293,-0.0401316485569426,0.00800046407272434,0.190743750080423
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23120.Arm fat mass (right),51334,-0.0186786404142301,0.0122544209792994,-0.0426973055336569,0.00534002470519665,0.127463831155824
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23121.Arm fat-free mass (right),51335,0.009543577326142,0.00951742295273084,-0.00911057166121045,0.0281977263134945,0.315993397387823
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23122.Arm predicted mass (right),51335,0.00770067887979383,0.00954149263669431,-0.011000646688127,0.0264020044477147,0.419633229364779
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23123.Arm fat percentage (left),51334,-0.0141885812134466,0.0125581840326292,-0.0388026219173999,0.0104254594905066,0.258561173599616
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23124.Arm fat mass (left),51334,-0.0213116828494058,0.0122599900387555,-0.0453412633253665,0.00271789762655499,0.0821698264183514
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23125.Arm fat-free mass (left),51334,0.00599299376917032,0.00971891234700298,-0.0130560744309555,0.0250420619692962,0.537483727189318
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23126.Arm predicted mass (left),51332,0.00685999089799809,0.00972319931259194,-0.0121974797546821,0.0259174615506783,0.480489038737034
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23127.Trunk fat percentage,51331,0.00517679590676157,0.00777762535976132,-0.0100673497983706,0.0204209416118938,0.505673045323025
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23128.Trunk fat mass,51331,0.0128339920259898,0.00869739243510106,-0.0042128971468083,0.0298808811987879,0.140061829554479
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23129.Trunk fat-free mass,51330,0.00519906440112753,0.00841844153040704,-0.0113010809984703,0.0216992098007253,0.536858327532211
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23130.Trunk predicted mass,51327,0.00488064943068097,0.00843860446321522,-0.0116590153172209,0.0214203141785828,0.563019127199374
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23400.Total Cholesterol,42370,-0.0577916205790706,0.00596637015769751,-0.0694857060881577,-0.0460975350699834,4.08878102952823e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42370,-0.0434897111782853,0.00580053866000784,-0.0548587669519007,-0.03212065540467,6.9184211139136e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42370,-0.0277231127052408,0.00580345907412946,-0.0390978924905345,-0.016348332919947,1.79849232372764e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23403.VLDL Cholesterol,42370,-0.00594096174203668,0.0059082681391043,-0.0175211672946811,0.00563924381060775,0.314658475972619
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23404.Clinical LDL Cholesterol,42370,-0.0548438609439516,0.00578319468709778,-0.0661789225306632,-0.0435087993572399,2.87958749200558e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23405.LDL Cholesterol,42370,-0.0566775039895836,0.00581229215300238,-0.0680695966094682,-0.0452854113696989,2.16765624741556e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23406.HDL Cholesterol,42370,-0.0702917197975903,0.0066604616554594,-0.0833462246422907,-0.0572372149528899,6.2051709528307e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23407.Total Triglycerides,42370,0.0133568830204136,0.00638248211793468,0.000847218069261663,0.0258665479715656,0.036391346744814
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23408.Triglycerides in VLDL,42370,0.0115493675636599,0.00635942340113247,-0.000915102302559753,0.0240138374298795,0.0693772979810695
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23409.Triglycerides in LDL,42370,0.00518819271740433,0.00632921713988508,-0.00721707287677043,0.0175934583115791,0.412389956768541
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23410.Triglycerides in HDL,42370,0.0232009428084904,0.00624406323512487,0.0109625788676456,0.0354393067493351,0.000203495575652116
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42370,-0.0518217982245947,0.00619528621893427,-0.0639645592137059,-0.0396790372354835,6.62790885777378e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23412.Phospholipids in VLDL,42370,0.00299294171238268,0.00609866400101156,-0.00896043972959997,0.0149463231543653,0.623608857921295
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23413.Phospholipids in LDL,42370,-0.054438296840195,0.00577874188786754,-0.0657646309404153,-0.0431119627399746,5.22991511925391e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23414.Phospholipids in HDL,42370,-0.0527129932802957,0.00663277658555572,-0.0657132353879849,-0.0397127511726065,2.05965676748813e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23415.Total Esterified Cholesterol,42370,-0.062130707098139,0.0059912753452085,-0.0738736067747477,-0.0503878074215304,4.23171266795082e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42370,-0.00821880225267344,0.00583805645130417,-0.0196613928972296,0.00322378839188274,0.159214583016827
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42370,-0.0546811893416439,0.00582283869932233,-0.0660939531923156,-0.0432684254909721,6.91897533893116e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42370,-0.0731981905101453,0.00662479019099772,-0.0861827792845009,-0.0602136017357898,2.94523141171174e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23419.Total Free Cholesterol,42370,-0.0464051494494241,0.00590927581642047,-0.0579873300496082,-0.03482296884924,4.37743211407433e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23420.Free Cholesterol in VLDL,42370,-0.00291949730115459,0.00602859093190392,-0.0147355355276863,0.00889654092537709,0.628198597102448
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23421.Free Cholesterol in LDL,42370,-0.0603052760263608,0.00581401038899505,-0.0717007363887912,-0.0489098156639306,4.13578681223523e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23422.Free Cholesterol in HDL,42370,-0.0551446265702943,0.00673641334545378,-0.0683479967273837,-0.0419412564132049,2.94600584788736e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42370,-0.0426146270680191,0.00597307620710114,-0.0543218564339373,-0.0309073977021009,1.02251968988619e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23424.Total Lipids in VLDL,42370,0.00505498380711876,0.00618107163623926,-0.0070599165999102,0.0171698842141477,0.413476630807123
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23425.Total Lipids in LDL,42370,-0.0538125500246681,0.00581110565487539,-0.0652023171082239,-0.0424227829411123,2.35009916321562e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23426.Total Lipids in HDL,42370,-0.0589620809770341,0.00666387365722996,-0.0720232733452049,-0.0459008886088634,1.00321808778058e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42370,-0.085778376730718,0.00626460613395571,-0.0980570047532712,-0.0734997487081649,2.1936389482931e-42
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23428.Concentration of VLDL Particles,42370,-0.00183667841043207,0.0060188410797117,-0.013633606926667,0.00996025010580285,0.760253055211733
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23429.Concentration of LDL Particles,42370,-0.034464240806735,0.00577743481369493,-0.045788013041577,-0.0231404685718929,2.5041687597614e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23430.Concentration of HDL Particles,42370,-0.0847672075453161,0.00627874178647767,-0.0970735414468124,-0.0724608736438199,2.91383447809103e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42370,0.00507427807454699,0.00646038977108829,-0.00758808587678605,0.01773664202588,0.432207079873534
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23432.Average Diameter for LDL Particles,42370,-0.0241642752162386,0.00614244347914306,-0.036203464435359,-0.0121250859971182,8.39777948899583e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23433.Average Diameter for HDL Particles,42370,0.00286098811319718,0.00690877850915714,-0.0106802177647508,0.0164021939911452,0.678800942734644
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23434.Phosphoglycerides,42360,-0.0504677064132532,0.0063163171782194,-0.0628476880825632,-0.0380877247439432,1.46048225468746e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42360,0.0409179613490032,0.00661722001094827,0.0279482101275446,0.0538877125704618,6.45261180016123e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23436.Total Cholines,42360,-0.0552331571903146,0.00631910332907718,-0.0676185997153059,-0.0428477146653234,2.59541775624774e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23437.Phosphatidylcholines,42360,-0.0524407133925204,0.00637259785913236,-0.0649310051964199,-0.039950421588621,2.06258384100197e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23438.Sphingomyelins,42360,-0.0601083391657378,0.00619403617522107,-0.0722486500691711,-0.0479680282623045,3.43250643850709e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23439.Apolipoprotein B,42370,-0.0308994891796642,0.00577685426456036,-0.0422221235382025,-0.0195768548211259,8.99977573321154e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23440.Apolipoprotein A1,42370,-0.0669086977755011,0.00650088330700735,-0.0796504290572355,-0.0541669664937667,9.47640005922427e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42370,0.00401962129773519,0.00592879866060399,-0.00760082407704863,0.015640066672519,0.497794741638804
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23442.Total Fatty Acids,42360,-0.0231364027960154,0.00616219270911111,-0.0352143005058731,-0.0110585050861576,0.000174384355036997
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23443.Degree of Unsaturation,42360,-0.0568823232083508,0.00624627111915271,-0.0691250146018901,-0.0446396318148115,9.71077820192674e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23444.Omega-3 Fatty Acids,42360,-0.0511655855180943,0.00620710899903632,-0.0633315191562055,-0.0389996518799831,1.83652280559891e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23445.Omega-6 Fatty Acids,42360,-0.0390831634654036,0.00606106037344172,-0.0509628417973494,-0.0272034851334578,1.17108519568999e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42360,-0.0471330806055842,0.00614520773008704,-0.0591776877565548,-0.0350884734546136,1.84203853554327e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42360,0.00140952835727402,0.00631482079857883,-0.0109675204079405,0.0137865771224885,0.823375876468072
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23448.Saturated Fatty Acids,42360,-0.0206828096344841,0.00616456102813119,-0.0327653492496212,-0.00860027001934697,0.000795562005230435
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23449.Linoleic Acid,42360,-0.0227956332562087,0.00594111111736909,-0.0344402110462521,-0.0111510554661653,0.00012516326099966
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23450.Docosahexaenoic Acid,42360,-0.0651891253829393,0.00618942435175509,-0.0773203971123793,-0.0530578536534994,7.76467903975725e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42360,-0.0474268630058251,0.0061349778476392,-0.0594514195871979,-0.0354023064244523,1.14814951839012e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42360,-0.0147236523525152,0.006611508459673,-0.0276822089334742,-0.00176509577155609,0.0259659075341018
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42360,-0.0339789248936944,0.00652096613759811,-0.0467600185233867,-0.0211978312640021,1.90951637261577e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42360,0.0512243259563185,0.00658682098316087,0.0383141568293232,0.0641344950833138,7.99024233462845e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42360,-0.00085049840786133,0.00599543941689956,-0.0126015596649845,0.0109005628492618,0.887194687781438
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42360,-0.00194767439876916,0.00634491804992387,-0.0143837137766199,0.0104883649790816,0.758874072197116
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42360,-0.0511058379851317,0.00611637115504436,-0.0630939254490186,-0.0391177505212448,7.15896490296141e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42360,-0.0458648026326248,0.00660897708871745,-0.058818397726511,-0.0329112075387386,4.1111207324232e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42360,0.0388951312981349,0.00607676525648114,0.0269846713954319,0.050805591200838,1.59982320880454e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23460.Alanine,42364,0.0224095183972109,0.00598941316225491,0.0106702685991913,0.0341487681952305,0.000183686070439755
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23461.Glutamine,42327,-0.0162312747785437,0.00601455101212709,-0.0280197947623128,-0.00444275479477463,0.00697066720313501
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23462.Glycine,42354,0.0149599534103638,0.0063886784029894,0.0024381437405046,0.027481763080223,0.0192143133166973
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23463.Histidine,42352,-0.0191321338101729,0.00591007117029469,-0.0307158733039505,-0.00754839431639535,0.00121003984189899
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42361,-0.00554777825891171,0.00625625862160445,-0.0178100451572564,0.00671448863943302,0.375226185492366
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23465.Isoleucine,42366,-0.000312091047673981,0.00609015183184425,-0.0122487886380887,0.0116246065427408,0.959130911918296
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23466.Leucine,42366,-0.0111825910174595,0.00616537237105971,-0.0232667208647365,0.00090153882981755,0.0697352990417488
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23467.Valine,42361,-0.00325130823387812,0.00631929764835739,-0.0156371316246586,0.00913451515690236,0.606907822557901
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23468.Phenylalanine,42364,0.0309687267338947,0.00597897413955331,0.0192499374203702,0.0426875160474192,2.25636619298139e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23469.Tyrosine,42354,0.00563821518960984,0.00607250378139081,-0.00626389222191615,0.0175403226011358,0.353174225443334
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23470.Glucose,42345,0.0237697983618026,0.00591827107430913,0.0121699870561567,0.0353696096674485,5.94371006284899e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23471.Lactate,42346,0.000520276460729468,0.00594066889019585,-0.0111234345640544,0.0121639874855133,0.930212811567522
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23472.Pyruvate,42331,-0.00198364438754076,0.00599188912074559,-0.0137277470642021,0.0097604582891206,0.740608280395353
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23473.Citrate,42367,0.0243085033812411,0.00599609944054943,0.0125561484777642,0.036060858284718,5.06272730136156e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23474.3-Hydroxybutyrate,42144,-0.00177880725617121,0.00630628841827847,-0.014139132555997,0.0105815180436546,0.777895257677088
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23475.Acetate,42358,-0.0132369436208741,0.00589329188388966,-0.0247877957132978,-0.00168609152845033,0.0247138922628501
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23476.Acetoacetate,42368,-0.0111579009265189,0.00605101433442574,-0.0230178890219934,0.000702087168955519,0.0652096639858581
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23477.Acetone,42368,-0.0256151836169379,0.00600710636182403,-0.037389112086113,-0.0138412551477628,2.02065916282863e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23478.Creatinine,42058,0.0543790787358722,0.00668500176468844,0.0412764752770829,0.0674816821946616,4.51435966118848e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23479.Albumin,42368,-0.0692876509014965,0.00598574136200784,-0.0810197039710318,-0.0575555978319611,7.73734344660484e-31
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23480.Glycoprotein Acetyls,42370,0.0400092299731825,0.00634323808725908,0.0275764833221547,0.0524419766242103,2.92863975512251e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42370,0.0338876354986049,0.00639720292766061,0.0213491177603901,0.0464261532368197,1.1944663062978e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42370,0.0346134602996758,0.00632292441057536,0.022220528454948,0.0470063921444035,4.47332614065086e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42370,0.0343957727187796,0.00640538762007376,0.021841212983435,0.0469503324541242,8.01534530780861e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42370,0.0331353578801796,0.00634764510606902,0.0206939734722843,0.0455767422880749,1.81542669370648e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42370,0.0338217088225122,0.00627271966513334,0.0215271782788508,0.0461162393661735,7.09295871016157e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42370,0.0311724335167493,0.00640406295891631,0.0186204701172733,0.0437243969162253,1.14269368300901e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42370,0.0335789560042156,0.00626222338101639,0.0213049981774234,0.0458529138310077,8.36271546067752e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42370,0.0141942918725559,0.00638303634560998,0.0016835406351603,0.0267050431099514,0.0261820006940689
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42370,0.0146380568603058,0.00635388738173514,0.00218443759210492,0.0270916761285067,0.0212496145439493
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42370,0.0177808264812699,0.0063286748241823,0.00537662382587257,0.0301850291366672,0.00496815169951807
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42370,0.0101149672322507,0.00618571460852253,-0.00200903340045348,0.0222389678649549,0.10202807783586
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42370,0.00495816001888456,0.00608773980154496,-0.00697380999214356,0.0168901300299127,0.415401892563757
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42370,0.015864931247354,0.00628222025731443,0.00355177954301769,0.0281780829516903,0.0115692792975977
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42370,0.0149235892424916,0.00639206746450361,0.00239513701206455,0.0274520414729187,0.0195737987595023
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42370,0.00768835157688669,0.00630714956784906,-0.00467366157609747,0.0200503647298709,0.222869851421279
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23496.Total Lipids in Large VLDL,42370,0.00427051788218788,0.00627406213376916,-0.00802664389999967,0.0165676796643754,0.496097124675322
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23497.Phospholipids in Large VLDL,42370,0.0107960000628256,0.00630010056947263,-0.0015521970533408,0.0231441971789919,0.0866214259194893
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23498.Cholesterol in Large VLDL,42370,0.00379413418234282,0.00617772922995218,-0.00831421510836345,0.0159024834730491,0.539118067734587
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42370,0.00163927769605204,0.00607008396282415,-0.0102580868710833,0.0135366422631874,0.787119487245866
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42370,0.00554960147864952,0.00629039673045886,-0.00677957611304985,0.0178787790703489,0.377666407046891
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23501.Triglycerides in Large VLDL,42370,0.00155965180111904,0.00626929083707789,-0.0107281582395536,0.0138474618417917,0.80353760056784
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42370,-0.0191133188627325,0.00591165602568142,-0.0307001646730681,-0.00752647305239695,0.00122731106814386
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42370,-0.0162574241634949,0.00597944941362079,-0.0279771450141916,-0.00453770331279815,0.00655885047288498
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42370,-0.0191822180742868,0.0058863345268091,-0.0307194337468327,-0.00764500240174101,0.00112179391376331
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42370,-0.0290174752522185,0.00577059392521865,-0.040327839345647,-0.01770711115879,5.00810161488701e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42370,-0.0324401890741487,0.00578402805215815,-0.0437768840563787,-0.0211034940919188,2.08097032602207e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42370,-0.0226883143755738,0.00584161756272679,-0.0341378847985183,-0.0112387439526293,0.000103292380977012
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42370,-0.00481707607589219,0.00621580939566155,-0.0170000624913888,0.00736591033960444,0.438370317847433
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42370,0.000352051148537683,0.00611032967312044,-0.0116241950107784,0.0123282973078537,0.954055587717739
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23510.Total Lipids in Small VLDL,42370,-0.00379796709942142,0.0060921175219382,-0.0157385174424203,0.00814258324357745,0.533017279929914
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23511.Phospholipids in Small VLDL,42370,-0.0165581336022204,0.00594231588646275,-0.0282050727396874,-0.00491119446475343,0.00533604107309688
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23512.Cholesterol in Small VLDL,42370,-0.0138249618909272,0.00588371228909848,-0.0253570379775602,-0.00229288580429417,0.0188031960735996
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42370,-0.00726047892473655,0.00591539233525541,-0.0188546479018372,0.00433369005236405,0.219698890648109
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42370,-0.0248224006051967,0.00583517009523552,-0.0362593339918583,-0.0133854672185351,2.11502010378723e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23515.Triglycerides in Small VLDL,42370,0.0134993342302127,0.00632590265415092,0.00110056502807689,0.0258981034323485,0.032863028674005
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42370,0.00243525436468606,0.00594907068935742,-0.00922492418645447,0.0140954329158266,0.682289200235701
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42370,0.00456351125214411,0.00600769636950532,-0.00721157363208631,0.0163385961363745,0.447500830976092
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42370,0.0128529678881831,0.00601254609462612,0.00106837754271595,0.0246375582336503,0.0325601490221473
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42370,-0.00906240252471415,0.00592010640461631,-0.0206658110777621,0.00254100602833381,0.125846860674138
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42370,-0.0136439891464632,0.00592351709716745,-0.0252540826569114,-0.00203389563601503,0.0212741204221705
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42370,0.00202610303148221,0.00595932217865987,-0.00965416843869114,0.0137063745016555,0.733870352190888
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42370,0.0247275677460403,0.00631703966579104,0.0123461700010899,0.0371089654909907,9.10765819976156e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23523.Concentration of IDL Particles,42370,-0.0293586869362671,0.00574397578496985,-0.040616879474808,-0.0181004943977261,3.24578971491181e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23524.Total Lipids in IDL,42370,-0.0422227012196855,0.00590624243412434,-0.0537989363905692,-0.0306464660488018,9.21344495138005e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23525.Phospholipids in IDL,42370,-0.0347849068944727,0.00592586011007218,-0.0463995927102141,-0.0231702210787312,4.46232960869375e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23526.Cholesterol in IDL,42370,-0.048542418076143,0.005896333586647,-0.0600992319059711,-0.0369856042463149,2.00252582905515e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42370,-0.0502978162949983,0.00589882725878522,-0.0618595177222173,-0.0387361148677793,1.66792669773653e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23528.Free Cholesterol in IDL,42370,-0.0423051151520379,0.00588581146216701,-0.0538413056178852,-0.0307689246861905,6.94687338069141e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23529.Triglycerides in IDL,42370,0.0188187424575349,0.00632012568337424,0.00643129611812135,0.0312061887969484,0.00291052957388906
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23530.Concentration of Large LDL Particles,42370,-0.0348907826907582,0.00577619627876325,-0.0462121273971341,-0.0235694379843822,1.57831937340922e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23531.Total Lipids in Large LDL,42370,-0.0558257853325551,0.00584226176414681,-0.0672766183902828,-0.0443749522748273,1.444451337031e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23532.Phospholipids in Large LDL,42370,-0.0553596868526684,0.00579780744422976,-0.0667233894433587,-0.043995984261978,1.54659139221142e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23533.Cholesterol in Large LDL,42370,-0.0588406587636315,0.00585123662407044,-0.0703090825468096,-0.0473722349804534,1.05131567335833e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42370,-0.0582179014875164,0.00585330641805364,-0.0696903820669015,-0.0467454209081312,3.16478113393994e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42370,-0.059311479051474,0.00585637042658571,-0.070789965087582,-0.0478329930153661,5.09822911479178e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23536.Triglycerides in Large LDL,42370,0.00439470880221804,0.00631479922578659,-0.00798229768032367,0.0167717152847597,0.486479927482648
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42370,-0.0357081268231708,0.00581305564547829,-0.0471017158883083,-0.0243145377580334,8.34413090651979e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23538.Total Lipids in Medium LDL,42370,-0.0513451376154278,0.00583323041268055,-0.0627782692242816,-0.0399120060065739,1.50744743290969e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23539.Phospholipids in Medium LDL,42370,-0.0532070648304665,0.00581915228674177,-0.0646126033124804,-0.0418015263484526,6.92552279798911e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23540.Cholesterol in Medium LDL,42370,-0.0533136290922364,0.00581829329121594,-0.0647174839430197,-0.0419097742414532,5.77918531791895e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42370,-0.0490509693426417,0.00585329786879375,-0.0605234331654775,-0.0375785055198059,5.82255656723784e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42370,-0.0621841087053414,0.00579011367335566,-0.0735327315051185,-0.0508354859055643,8.55266216648773e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23543.Triglycerides in Medium LDL,42370,0.00282254595681147,0.00634018028431703,-0.00960420740044991,0.0152492993140729,0.656194200215854
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23544.Concentration of Small LDL Particles,42370,-0.0256487244911652,0.00578449581777127,-0.0369863362939969,-0.0143111126883335,9.32289120722639e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23545.Total Lipids in Small LDL,42370,-0.0448577221658917,0.00577994366985504,-0.0561864117588076,-0.0335290325729758,9.05044100694903e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23546.Phospholipids in Small LDL,42370,-0.047250646096936,0.00573522046975497,-0.0584916782176558,-0.0360096139762163,1.90455509649451e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23547.Cholesterol in Small LDL,42370,-0.0472095157950174,0.00577565646067281,-0.058529802457936,-0.0358892291320987,3.25749576157416e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42370,-0.0416724466618608,0.00581524433390351,-0.0530703255563117,-0.03027456776741,8.1287622104251e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42370,-0.057139143516155,0.0057516061999011,-0.0684122916679612,-0.0458659953643489,3.55572096520932e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23550.Triglycerides in Small LDL,42370,0.0140781706486004,0.00637630913560001,0.00158060474282437,0.0265757365543764,0.0272693063287044
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42370,-0.001340823201187,0.00661515096111508,-0.0143065190849726,0.0116248726825986,0.839380675828035
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42370,0.0050037912323735,0.00664891959898584,-0.00802809118163876,0.0180356736463857,0.451720546877715
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42370,0.0125215888913161,0.00669248909319134,-0.00059568973133896,0.0256388675139711,0.061368432623149
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42370,-0.00730632561993944,0.00657685079223923,-0.0201969531727283,0.00558430193284946,0.266624985935077
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42370,-0.0137595333803092,0.00664260356167034,-0.0267790363611831,-0.000740030399435343,0.0383402241943722
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42370,0.0144461796662013,0.00629459084839465,0.00210878160334782,0.0267835777290549,0.0217479123605795
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42370,0.0292482704545419,0.00621328067067695,0.0170702403400151,0.0414263005690687,2.53476907078816e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23558.Concentration of Large HDL Particles,42370,-0.0309084599611474,0.00690825342510443,-0.0444486366743521,-0.0173682832479427,7.73637916421429e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23559.Total Lipids in Large HDL,42370,-0.0287788357995177,0.00692006822714774,-0.0423421695247273,-0.0152155020743081,3.22020177549152e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23560.Phospholipids in Large HDL,42370,-0.0279192224824637,0.00691621453320311,-0.0414750029675418,-0.0143634419973856,5.44967899882857e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23561.Cholesterol in Large HDL,42370,-0.0330528042309838,0.00684427527750561,-0.0464675837748948,-0.0196380246870728,1.38579846181457e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42370,-0.0356328833794788,0.00683143117942474,-0.0490224884911512,-0.0222432782678063,1.85578819542415e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42370,-0.0236177835648162,0.00685840725566961,-0.0370602617859287,-0.0101753053437038,0.000575756077292423
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23564.Triglycerides in Large HDL,42370,0.0293932620798254,0.00641078693399958,0.0168281196891862,0.0419584044704646,4.58230885432309e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42370,-0.0656312804277806,0.00645198399744523,-0.0782771690627733,-0.052985391792788,3.24029718315659e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23566.Total Lipids in Medium HDL,42370,-0.0623971590001685,0.00640220031114321,-0.0749454716100092,-0.0498488463903278,2.27876372586053e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23567.Phospholipids in Medium HDL,42370,-0.0559905155542335,0.00637495154852084,-0.0684854205893344,-0.0434956105191327,1.78805827975919e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23568.Cholesterol in Medium HDL,42370,-0.0735552431549483,0.00642719316524514,-0.0861525417588288,-0.0609579445510678,3.4837697629778e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42370,-0.0747452801731108,0.00639356473752616,-0.087276667058662,-0.0622138932875595,2.03236910667366e-31
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42370,-0.0658048910386878,0.00654391322935698,-0.0786309609682274,-0.0529788211091481,1.05358030353004e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23571.Triglycerides in Medium HDL,42370,0.0196405379956338,0.00621569018779741,0.0074577852275509,0.0318232907637167,0.00158217057804415
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23572.Concentration of Small HDL Particles,42370,-0.0898734702659184,0.00589038202288236,-0.101418619030768,-0.078328321501069,4.08043207002111e-52
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23573.Total Lipids in Small HDL,42370,-0.074348918765275,0.00595749375401064,-0.0860256065231359,-0.0626722310074142,1.52627549771992e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23574.Phospholipids in Small HDL,42370,-0.0671287235745353,0.00600203919463087,-0.0788927203960118,-0.0553647267530588,6.56697169727078e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23575.Cholesterol in Small HDL,42370,-0.0936306044013052,0.00588056715079371,-0.105156516016861,-0.0821046927857495,1.49967114389449e-56
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42370,-0.0955166056056645,0.00584476493859274,-0.106972344885306,-0.0840608663260228,1.8965584305084e-59
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42370,-0.0739481935285812,0.00605844473782832,-0.0858227452147248,-0.0620736418424377,4.42090289093104e-34
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23578.Triglycerides in Small HDL,42370,0.0173923240137105,0.00632740637758718,0.00499060751363961,0.0297940405137813,0.00599083292081461
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41887,0.00129615454653938,0.0060700785573112,-0.0106011994257906,0.0131935085188693,0.830915650379644
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41887,-0.00998896309578737,0.00625168296623102,-0.0222422617096002,0.00226433551802543,0.110111529883911
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41887,-0.00376761087571219,0.00619035180314227,-0.015900700409871,0.00836547865844666,0.542783063210107
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41887,-0.019510797982085,0.00628342706845347,-0.0318263150362538,-0.00719528092791623,0.00190620326837136
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41887,0.0091513157548468,0.0062071146882107,-0.00301462903404616,0.0213172605437398,0.140418413692588
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42256,0.0260349189233302,0.00605510828420081,0.0141669066862966,0.0379029311603637,1.72299889146801e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42256,-0.0159465605343132,0.00634090546895573,-0.0283747352534664,-0.00351838581515995,0.0119194971125729
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42256,-0.0206461767666824,0.00634687109847003,-0.0330860441196836,-0.00820630941368113,0.00114495868049677
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42256,0.0061594388418833,0.00626269161173191,-0.00611543671711123,0.0184343144008778,0.325373219057199
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42256,0.00638192086337499,0.00621996621347153,-0.00580921291502921,0.0185730546417792,0.304892735853953
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42369,0.0400202300130765,0.00617720760428215,0.0279129031086834,0.0521275569174695,9.58099173163106e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42369,-0.00166907496846492,0.00601310489277782,-0.0134547605583095,0.0101166106213796,0.781344592091951
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42369,-0.00507197058728294,0.00618698162023565,-0.0171984545629448,0.00705451338837893,0.412355738107422
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42369,0.00695044363809265,0.00593854286172851,-0.00468910037089523,0.0185899876470805,0.241863029310623
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42369,-0.0133387877094332,0.00591466422447109,-0.0249315295893965,-0.00174604582946988,0.024136727230067
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42370,-0.0189235496900306,0.00600213562767782,-0.0306877355202791,-0.00715936385978208,0.00162073794680115
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42370,-0.0272637793245186,0.00622931015048382,-0.0394732272194669,-0.0150543314295703,1.21420945667769e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42370,-0.0283476008851432,0.00629424193995355,-0.0406843150874522,-0.0160108866828343,6.73428913835589e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42370,-0.0236439674307743,0.0060782861744531,-0.0355574083327024,-0.0117305265288462,0.000100775527922554
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42370,0.0256919635928062,0.00617234893864434,0.0135941596730633,0.0377897675125491,3.16881257753302e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42370,-0.0493587500618357,0.00619142591238411,-0.0614939448501086,-0.0372235552735628,1.68769280088251e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42370,-0.0285587401026381,0.00604913723171225,-0.0404150490767941,-0.0167024311284821,2.36958058388937e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42370,-0.0111791545126127,0.00594112061942162,-0.0228237509266791,0.000465441901453638,0.0599045512133331
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42370,-0.0486554378167807,0.00621632136648607,-0.0608394276950934,-0.036471447938468,5.37446014963427e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42370,0.0352436536231669,0.00609761656320589,0.0232923251592834,0.0471949820870505,7.64345730659183e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42370,0.0691809041942041,0.006044969128651,0.0573327647020482,0.0810290436863601,3.48391259614014e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42370,-0.040213321946585,0.00627568269572089,-0.052513660030198,-0.0279129838629721,1.52657731312832e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42370,-0.0428318820384566,0.00632619547098753,-0.0552312251615922,-0.0304325389153211,1.33721138939672e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42370,-0.0146491287707137,0.00595851912956384,-0.0263278262646588,-0.00297043127676854,0.0139639332286968
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42370,0.0291565114442801,0.00625577673222224,0.0168951890491245,0.0414178338394357,3.18171768662505e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42370,0.0586705713427639,0.00569321364675804,0.0475118725951182,0.0698292700904097,8.27863041433297e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42370,-0.0647478458081649,0.00602699390712457,-0.0765607538661291,-0.0529349377502008,8.25746285179263e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42370,-0.0692276163155225,0.00601222483029766,-0.0810115769829059,-0.0574436556481391,1.56122812803453e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42370,-0.0189047206765266,0.00582311620704235,-0.0303180284423296,-0.00749141291072357,0.00117127266184486
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42370,0.0597291601360689,0.00623072497024848,0.0475169391943819,0.0719413810777559,1.07531790144665e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42370,0.011152401204323,0.00581341248388442,-0.00024188726409048,0.0225466896727364,0.0550829710198547
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42370,-0.0779485387897843,0.00625656191076379,-0.0902114001348813,-0.0656856774446872,1.98559067983248e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42370,-0.0584434668791404,0.00585338976694588,-0.0699161108223543,-0.0469708229359265,2.15671023683794e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42370,-0.0400919414077003,0.006269641400417,-0.0523804385525176,-0.027803444262883,1.66384938142352e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42370,0.069097421491853,0.00624333777406273,0.05686047945469,0.0813343635290159,2.40753962220908e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42370,-0.00551201502301418,0.0059532665257026,-0.0171804174133913,0.00615638736736292,0.354524901056272
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42370,-0.0547588422921059,0.00577764571308643,-0.0660830278897553,-0.0434346566944565,3.03745577811687e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42370,-0.00964995134807487,0.00600091145805796,-0.0214117378058685,0.00211183510971872,0.107841411999918
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42370,-0.0455486027975845,0.00640673513352598,-0.0581058036592954,-0.0329914019358735,1.2247693876033e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42370,0.0669714644149075,0.0061339477238259,0.0549489268762087,0.0789940019536062,1.23944954862278e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42370,0.00083538379808651,0.00588471810640627,-0.0106986636904698,0.0123694312866428,0.887115218952667
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42370,-0.0452247074018273,0.00590886311521415,-0.0568060791076471,-0.0336433356960076,2.08822635525746e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42370,-0.0024158389070823,0.00588690632673374,-0.0139541753074804,0.00912249749331584,0.681537589571356
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42370,-0.0516863678514496,0.00627811329310036,-0.0639914699059263,-0.0393812657969729,2.00016025910729e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42370,0.0594581666498936,0.0062687420125117,0.0471714323053707,0.0717449009944165,2.8374387940666e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42361,0.0388441353684452,0.00653788859626401,0.0260298737197677,0.0516583970171226,2.89755404802455e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42361,-0.0589388622308831,0.00616945071796798,-0.0710309856381004,-0.0468467388236659,1.47497112414974e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42361,-0.0830526800378302,0.00596903200950153,-0.0947519827764532,-0.0713533772992072,1.06257101482124e-43
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42361,0.0155875943854348,0.00685857009251857,0.00214479700409838,0.0290303917667712,0.023059234881349
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42361,0.0172093210912218,0.00652903381099758,0.00441241482166659,0.0300062273607771,0.00840340414814834
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42370,0.0134811755293388,0.00636739277546276,0.00100108568943175,0.0259612653692458,0.0342598096178917
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42370,-0.0346973147589455,0.00656887811161457,-0.0475723158577101,-0.021822313660181,1.29761129762642e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42370,-0.0430369959477884,0.00661727061129837,-0.0560068463459332,-0.0300671455496435,8.11763896643383e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42370,0.00904102822592234,0.00624084075532224,-0.00319101965450924,0.0212730761063539,0.147448659068421
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42370,0.0480818546450352,0.00648767897131303,0.0353660038612616,0.0607977054288087,1.32731218723463e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42370,0.0690412753942618,0.00643746136534024,0.056423851118195,0.0816586996703287,1.00226867656147e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42370,-0.0672423591933617,0.0063854786901152,-0.0797578974259875,-0.0547268209607359,7.91432231970272e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42370,-0.0629884242628178,0.00635482601127733,-0.0754438832449214,-0.0505329652807142,4.45047612675646e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42370,-0.0570422952065057,0.00668363637328044,-0.0701422224981353,-0.043942367914876,1.55878805036869e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42370,0.0608285798668061,0.00630587837562088,0.0484690582505892,0.0731881014830231,6.02076973567805e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42370,0.0446303035392028,0.00618389372934827,0.0325098718296802,0.0567507352487254,5.59804695759663e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42370,-0.0694816952220643,0.0061599731501778,-0.0815552425964128,-0.0574081478477158,2.25772907991274e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42370,-0.0701828007237514,0.00622371526114516,-0.0823812826355959,-0.0579843188119069,2.33192125244508e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42370,-0.00713008109572859,0.00617427957639821,-0.0192316690654691,0.0049715068740119,0.248191751429886
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42370,0.0610210945019221,0.00636795011695616,0.0485399122726881,0.0735022767311562,1.11423953201912e-21
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51632,0.00889290925460434,0.00515013372474646,-0.00120135284589872,0.0189871713551074,0.0842292712145982
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51632,0.00727752714115325,0.00501599774996386,-0.00255382844877591,0.0171088827310824,0.146831903161427
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50202,0.00772782648880456,0.00476925145841987,-0.00161990636969838,0.0170755593473075,0.105173478297664
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50202,0.00978875905492544,0.00524160787101499,-0.000484792372263952,0.0200623104821148,0.0618442108828615
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50202,0.00535349651867186,0.00510987839565015,-0.00466186513680244,0.0153688581741462,0.294800001431409
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50202,-0.000707430819631814,0.00465745266850267,-0.00983603804989704,0.00842117641063342,0.879273404166527
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24009.Traffic intensity on the nearest road,51632,-0.0468207252115633,0.0410878786944495,-0.127352967452684,0.0337115170295577,0.25449580096188
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24010.Inverse distance to the nearest road,51632,0.00969640948140317,0.00449189671141321,0.000892291927033268,0.0185005270357731,0.030888303409101
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24011.Traffic intensity on the nearest major road,51632,0.00794531346568355,0.00443962835168758,-0.000756358103624111,0.0166469850349912,0.0735261187443793
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24012.Inverse distance to the nearest major road,51632,0.00019969990489734,0.00452449794513668,-0.00866831606757056,0.00906771587736524,0.964795215674195
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24013.Total traffic load on major roads,51632,-0.0233626805311336,0.0288928107129037,-0.0799925895284248,0.0332672284661577,0.418754758561669
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24015.Sum of road length of major roads within 100m,51632,-0.0144640800223812,0.0281265284895454,-0.0695920758618902,0.0406639158171279,0.607081962309334
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51632,0.0100723862537246,0.00511086911113666,5.50827958967267e-05,0.0200896897115524,0.0487615945196055
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51632,0.0103597133901017,0.00510013082180669,0.000363456979360589,0.0203559698008428,0.042239958659838
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51632,0.00843713828299243,0.0050427688892094,-0.00144668873985799,0.0183209653058428,0.0943183644599521
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51578,0.00372732200891756,0.00502247447663557,-0.00611672796528816,0.0135713719831233,0.458017203187745
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24020.Average daytime sound level of noise pollution,51632,-0.000539150540415324,0.00452101069304635,-0.00940033149878616,0.00832203041795552,0.905074855226877
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24021.Average evening sound level of noise pollution,51632,-0.000524566898810863,0.00452191795764361,-0.00938752609579233,0.00833839229817061,0.907649300710688
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24022.Average night-time sound level of noise pollution,51632,-0.000549038775194295,0.0045210203529484,-0.00941023866697315,0.00831216111658456,0.903342561110724
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51632,-0.000498110503669779,0.00452140943085022,-0.00936007298813621,0.00836385198079665,0.912277849811537
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51632,-0.00053730481612608,0.00452127046230651,-0.00939899492224684,0.00832438528999468,0.905403701315787
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2405.Number of children fathered,39904,0.0103624091066263,0.0322011266082082,-0.0527517990454617,0.0734766172587143,0.747608457961995
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49391,-0.00977319948539259,0.0052282591813054,-0.0200205874807512,0.000474188509966004,0.0615951597107497
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49391,0.00930242488859571,0.0046940638864395,0.0001020596711743,0.0185027901060171,0.0475216270030663
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24502.Water percentage, buffer 1000m",49391,-0.00917723109684798,0.0047704962535316,-0.0185274037537699,0.000172941560073962,0.0544002563217217
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49391,-0.00890935475187472,0.00489823438995683,-0.0185098941561901,0.000691184652440668,0.0689428534542674
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49391,0.00856342287018982,0.00471593645222152,-0.000679812576164358,0.017806658316544,0.0694085420550522
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24505.Water percentage, buffer 300m",49391,-0.00805410961960995,0.00480607703966597,-0.0174740206173553,0.00136580137813535,0.0937893580790351
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51773,-0.0111362717998485,0.00504348076572225,-0.0210214941006641,-0.00125104949903286,0.0272506057678331
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51773,-0.00862811030938536,0.00471590516920951,-0.017871284441036,0.000615063822265274,0.0673264366324568
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24508.Distance (Euclidean) to coast,51773,0.00217032136545654,0.00445406674274886,-0.00655964945033122,0.0109002921812443,0.626073602155574
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35413,-0.025591281916429,0.0381915062735166,-0.100446634212522,0.0492640703796635,0.502833051879978
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2704.Years since last cervical smear test,38267,0.025638075734111,0.0338549578983528,-0.0407176417466606,0.0919937932148825,0.448894839391287
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2714.Age when periods started (menarche),40660,0.0308835767178756,0.0266687125169103,-0.0213870998152686,0.0831542532510197,0.246869678322816
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2734.Number of live births,41010,0.0606154716120464,0.0258913114578641,0.00986850115463282,0.11136244206946,0.0192409293921996
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2744.Birth weight of first child,39211,-0.0452361193116967,0.0279459454943484,-0.10001017248062,0.00953793385722614,0.105543200895699
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2754.Age at first live birth,38010,-0.00489267998393476,0.00800701291787283,-0.0205864253029655,0.010801065335096,0.541182666551179
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2764.Age at last live birth,37981,0.000680154434230196,0.00737335671968553,-0.0137716247363534,0.0151319336048138,0.926505580485935
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2794.Age started oral contraceptive pill,36946,0.00543439556284554,0.0113502117156523,-0.016812019399833,0.0276808105255241,0.632099797663391
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2804.Age when last used oral contraceptive pill,36173,0.00171679319026603,0.00856707178744415,-0.0150746675131245,0.0185082538936566,0.84117797890574
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2867.Age started smoking in former smokers,36133,-0.0171467853154196,0.0083697555302813,-0.0335515061547709,-0.000742064476068227,0.0405328832727585
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35938,-0.0436602074728406,0.0433356064020861,-0.128597996020929,0.0412775810752482,0.313735324761843
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35933,0.00278233338910271,0.0476151652589059,-0.0905433905183528,0.0961080572965583,0.95340485296944
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35951,-0.00807986890553494,0.049654568225726,-0.105402822627958,0.0892430848168881,0.870742536524662
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35925,-0.0343840877115858,0.0485733536258675,-0.129587860818286,0.0608196853951145,0.479044526313048
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28739.Difficulty with standing for long periods,35958,0.0911245078075109,0.0370951513530558,0.0184180111555215,0.1638310044595,0.0140544548889819
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28740.Difficulty with taking care of household responsibilities,35979,0.0978781589217097,0.0418323409606148,0.0158867706389047,0.179869547204515,0.0193243475823945
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28741.Difficulty learning a new task,35918,0.0478320673107752,0.047291419979599,-0.0448591158492388,0.140523250470789,0.311846002306196
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28742.Difficulty with joining in community activities,35656,0.0145832691220094,0.0508870519230513,-0.0851553526471712,0.11432189089119,0.774442252273732
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28743.Difficulty with being emotionally affected by health problems,35936,0.0689700996873781,0.0427014503514908,-0.0147247430015439,0.1526649423763,0.106320707861809
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35981,0.015512220758294,0.0651121233546141,-0.11210754101675,0.143131982533338,0.811703239869624
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35660,0.044189750558638,0.0376080876470486,-0.0295221012295774,0.117901602346853,0.240035349261103
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2897.Age stopped smoking,36136,0.0160475518953567,0.00789516504516826,0.000573028406826891,0.0315220753838865,0.0421329859847373
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35252,0.0137151564660817,0.0193140596141803,-0.0241404003777117,0.0515707133098752,0.47766166647445
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35252,-0.000735179195021696,0.0217249343797739,-0.0433160505793785,0.0418456921893351,0.973005581488562
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35252,0.0245355398644115,0.0708173667118147,-0.114266498890745,0.163337578619568,0.729007428408746
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35252,-0.088973352089552,0.0844717148761833,-0.254537913246871,0.0765912090677672,0.292249352294456
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35252,0.0288964444461374,0.101233237605419,-0.169520701260485,0.22731359015276,0.775313577586335
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35252,0.100967193425475,0.0858322882006494,-0.0672640914477976,0.269198478298748,0.23950879823138
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35252,-0.00583252936463841,0.0351003211339234,-0.0746291587871282,0.0629641000578514,0.868030753135013
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35252,-0.0198993269329084,0.0601308650993193,-0.137755822527574,0.0979571686617575,0.740706045816032
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29002.Recent lack of interest or pleasure in doing things,35210,-0.0396880193997902,0.0506055891929378,-0.138874974217948,0.0594989354183679,0.432917525794426
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29003.Recent feelings of depression,35198,-0.0498215413548629,0.0490675972338407,-0.145994031933191,0.0463509492234649,0.309972599402893
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35211,-0.0314441514356871,0.0381278718670168,-0.10617478029504,0.0432864774236658,0.409573211726187
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29005.Recent feelings of tiredness or low energy,35215,0.0529551205148196,0.0377464310950472,-0.0210278844314729,0.126938125461112,0.16069308615455
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29006.Recent poor appetite or overeating,35226,-0.0587444920075672,0.0585811802854726,-0.173563605367093,0.0560746213519591,0.316003501649499
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29007.Recent feelings of inadequacy,35191,-2.28088787777629e-06,0.0553056928876524,-0.108401438947676,0.108396877171921,0.999967095442859
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29008.Recent trouble concentrating on things,35225,-0.0730662237421897,0.053187095272146,-0.177312930475596,0.0311804829912165,0.169567745933427
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35219,0.088140959407813,0.0907270188183238,-0.0896839974761017,0.265965916291728,0.331340226986041
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29010.Recent thoughts of suicide or self-harm,35197,0.0576324936464733,0.103039376703986,-0.144324684693339,0.259589671986286,0.575960847627695
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#0.Substances taken for depression_None of options listed,36227,-0.0315019097085338,0.0376083237911743,-0.105214224339235,0.0422104049221678,0.402266263221058
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36227,-0.125400433060492,0.0970986748474264,-0.315713835761448,0.0649129696404633,0.196581739324775
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36227,-0.0511710005825865,0.0392924662116952,-0.128184234357509,0.0258422331923362,0.192852828845087
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36227,0.0146009844428616,0.118049161943532,-0.21677537296646,0.245977341852184,0.901567727849731
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36227,-0.11962460296217,0.101201674254496,-0.317979884500983,0.0787306785766426,0.237229103251558
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36227,-0.189071131103542,0.104659172009266,-0.394203108241703,0.016060846034619,0.0708765332646663
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36227,0.0437897525057967,0.107288222334407,-0.166495163269641,0.254074668281235,0.68317553691589
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36227,-0.0525703744845467,0.106028053554964,-0.260385359452277,0.155244610483183,0.620039933732257
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36227,-0.0397804031024286,0.0692418088408536,-0.175494348430502,0.0959335422256444,0.565638262617457
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36227,-0.0584624491157652,0.0347521267508192,-0.126576617547371,0.00965171931584039,0.0925609494583428
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36227,-0.0456896564478681,0.0626329649349811,-0.168450267720431,0.0770709548246949,0.465730817160682
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36227,-0.161902644887647,0.0970804058030624,-0.35218024026165,0.028374950486355,0.0954164348284672
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36227,-0.11810729420665,0.135431893619604,-0.383553805701074,0.147339217287773,0.383195116510576
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36227,-0.186960326898525,0.0915795972446546,-0.366456337498048,-0.00746431629900154,0.0412377661790821
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36227,-0.327379906284721,0.128007212743169,-0.578274043261332,-0.0764857693081106,0.0105631984671695
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36227,-0.247739223748519,0.130473523326411,-0.503467329468283,0.0079888819712462,0.0576355998126955
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36227,-0.148126119227054,0.0761671234450705,-0.297413681179392,0.00116144272528415,0.0518447156867912
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36227,-0.158061294928033,0.0702809795266618,-0.29581201480029,-0.0203105750557756,0.0245438828661212
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36227,-0.0583039819720629,0.101143404083273,-0.256545053975279,0.139937090031153,0.56433039463
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29058.Recent feelings or nervousness or anxiety,35123,-0.0526192060381133,0.0451991636907864,-0.141209566872055,0.0359711547958281,0.244404711918305
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29059.Recent inability to stop or control worrying,35136,-0.0834354007717108,0.0462215524749082,-0.174029643622531,0.00715884207910927,0.071106685366692
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29060.Recent worrying too much about different things,35133,-0.0279838019795292,0.0428583793758489,-0.111986225556193,0.0560186215971346,0.513822472532781
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29061.Recent trouble relaxing,35130,-0.112410204203244,0.04640280985768,-0.203359711524297,-0.0214606968821914,0.0154444265517894
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29062.Recent restlessness,35146,0.00322351438343369,0.0684925127677001,-0.131021810641259,0.137468839408126,0.962463999448336
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29063.Recent easy annoyance or irritability,35117,-0.0651242578134931,0.0470787809786702,-0.157398668531687,0.0271501529047006,0.166623879473555
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29064.Recent feelings of foreboding,35118,-0.0310533603964525,0.053539936579934,-0.135991636093123,0.0738849153002181,0.561934199979956
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36227,-0.0793093724937937,0.0437791118409941,-0.165116431702142,0.00649768671455475,0.0700937232244504
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36227,-0.062770676711312,0.0781232379470276,-0.215892223087486,0.090350869664862,0.42172289776049
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36227,0.000665009112782261,0.0942837111774961,-0.18413106479511,0.185461083020675,0.994372546046345
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36227,0.135191588308069,0.0907433374644386,-0.0426653531222309,0.313048529738368,0.136315400633648
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#2.Symptoms of panic attack_Sweating,36227,-0.0620274194485059,0.0676629032465968,-0.194646709811836,0.0705918709148238,0.359324822147817
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36227,-0.00483143436942918,0.0719369821563885,-0.145827919395951,0.136165050657092,0.946454614808306
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36227,0.131458491746569,0.0722847907623431,-0.0102196981476235,0.273136681640761,0.0690120938271486
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36227,0.0126012675925415,0.0719097854706023,-0.128341911929839,0.153544447114922,0.860898320149826
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36227,-0.20053042680419,0.0925347005159749,-0.381898439815501,-0.0191624137928796,0.0302619412378264
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29076.Felt loved as a child,35115,-0.00447646450407692,0.0392555716075214,-0.0814173848548189,0.0724644558466651,0.909214817408659
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29077.Physically abused by family as a child,35136,0.0468435054026219,0.0586183827926387,-0.0680485248709499,0.161735535676194,0.424248999389194
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29078.Felt hated by family member as a child,35123,-0.0526834895579653,0.0578624081344318,-0.166093809501452,0.0607268303855211,0.362598036920984
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29079.Sexually molested as a child,35080,-0.109036312419263,0.0737015878080842,-0.253491424523108,0.0354187996845825,0.139079070210537
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29080.Someone to take to doctor when needed as a child,35096,-0.0213565114055157,0.0542262466900758,-0.127639954918064,0.0849269321070329,0.693712773419831
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35129,0.0143425858819881,0.0864606394217415,-0.155120267384625,0.183805439148601,0.86825253266513
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35081,-0.0362904001394461,0.0645096719768152,-0.162729357214004,0.0901485569351118,0.573757659560082
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35134,-0.141856625954669,0.0748829099607576,-0.288627129477753,0.00491387756841638,0.0582232337598549
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35121,-0.104588582637571,0.105034274969218,-0.310455761577238,0.101278596302096,0.319409031954894
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35122,-0.077365297478138,0.0954712744265731,-0.264488995354221,0.109758400397945,0.417770676364066
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29086.Experienced a violent or sexual assault,35135,-0.101088206492688,0.09139161699738,-0.280215775807553,0.0780393628221768,0.268728322642157
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29087.Experienced a life-threatening injury or illness,35128,0.0537639665244597,0.0437514119673171,-0.0319888009314819,0.139516733980401,0.219176411929523
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29088.Experienced a marital separation or divorce,35134,-0.0776398030769487,0.0441817660495085,-0.164236064533985,0.00895645838008804,0.078921346972187
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29089.Experienced the death of a spouse or partner,35142,-0.0384932201775717,0.0479063760444657,-0.132389717224725,0.0554032768695812,0.421712519457089
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35134,-0.00234037489750433,0.0565814889984449,-0.113240093334456,0.108559343539448,0.967007973375704
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29091.Frequency of drinking alcohol,35132,-0.0548800741616736,0.0354414542489655,-0.124345324489646,0.0145851761662989,0.121562188514315
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34402,-0.0477568505484226,0.0437899628416535,-0.133585177718064,0.0380714766212183,0.275504267828053
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34424,-0.105376425612203,0.0453528950420685,-0.194268099894657,-0.0164847513297486,0.0201916893427451
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29104.Ever used cannabis,35133,-0.236419932914975,0.0643188531814596,-0.362484885150635,-0.110354980679314,0.000239246144110864
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29108.Ever thought that life not worth living,35100,-0.066251296895705,0.0484482802012003,-0.161209926090058,0.0287073322986475,0.171531843103862
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29109.Ever contemplated self-harm,35125,-0.0440956471147139,0.0732119580407129,-0.187591084874511,0.0993997906450833,0.546996719054411
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29111.Ever self-harmed,35133,-0.000277733929543586,0.129244423388133,-0.253596803770284,0.253041335911196,0.998285495741437
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35122,-0.0698333574519766,0.0725548618898909,-0.212040886756163,0.0723741718522095,0.335842592211479
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36847,-0.0440481848752679,0.103526636790997,-0.246960392985623,0.158864023235087,0.670501074977811
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36847,-0.159921060084844,0.0761063850754066,-0.309089574832641,-0.0107525453370466,0.0356487379836976
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36847,-0.092324709030072,0.0908146754521114,-0.27032147291621,0.0856720548560663,0.309362739034833
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36847,-0.085866528784312,0.128259048190513,-0.337254263237717,0.165521205669093,0.503211215578003
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35113,-0.0596496138504194,0.041075094134072,-0.140156798353201,0.0208575706523617,0.146496564865399
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X29153.Pain or discomfort today,35124,0.0429154533785489,0.0373355256700354,-0.0302621769347205,0.116093083691818,0.250415380566961
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29154.Anxiety or depression today,35124,0.0089747663944703,0.0484060426743787,-0.0859010772473119,0.103850610036252,0.852917017371839
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29166.Frequency of confiding in someone close,34948,0.0478347676836803,0.0368215033900985,-0.0243353789609129,0.120004914328273,0.193962142631788
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35104,0.0119836154445503,0.0186931795898109,-0.0246550165514791,0.0486222474405796,0.521502798734495
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35104,0.000890687887173132,0.0191109020852921,-0.0365666801999993,0.0383480559743456,0.962828608399749
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35104,-0.0367319326316711,0.023827601476593,-0.0834340315257933,0.00997016626245116,0.123231484985521
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35104,0.0216309967076476,0.0221431543645721,-0.0217695858469136,0.0650315792622088,0.328673196963248
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35104,-0.0747532960042897,0.0378029187550516,-0.148847016764191,-0.000659575244388561,0.0480374331172201
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35104,-0.0158858362591886,0.0180188612297607,-0.0512028042695195,0.0194311317511423,0.378016753581188
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35103,-0.00640627294799386,0.0193284872850517,-0.0442901080266952,0.0314775621307075,0.740322380077135
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35103,0.00666938119017787,0.0298536499211239,-0.051843772655225,0.0651825350355807,0.823229950954515
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35103,-0.0652411878766543,0.0428723406761423,-0.149270975601893,0.0187885998485846,0.128124052862447
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35103,0.0305147076636466,0.0345387859897942,-0.0371813128763501,0.0982107282036433,0.377006968792799
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35103,-0.111738332143127,0.0577149501484722,-0.224859634434132,0.00138297014787879,0.052910690582809
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35103,0.0114515501430396,0.0262199930900814,-0.0399396363135199,0.0628427365995991,0.662309502773718
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29171.Frequency of feeling 'in tune' with people,35003,0.0081329955517869,0.0474476179208065,-0.0848643355729938,0.101130326676568,0.863907374225126
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29172.Freuency of feeling that lacks companionship,35087,0.0119370802929391,0.043135289095848,-0.072608086334923,0.0964822469208012,0.781992659967117
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29173.Frequency of feeling left out,35045,0.0138263728565515,0.0458776731834922,-0.0760938665830932,0.103746612296196,0.763139448480443
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29174.Frequency of feeling isolated from others,35075,-0.0111148527637627,0.0476067179837366,-0.104424020011886,0.082194314484361,0.81540275788089
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29175.Tendency to bounce back quickly after hard times,35119,-0.0245354994316599,0.0377156883741199,-0.0984582486449349,0.0493872497816152,0.515369813851478
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29176.Ability to make it through stressful events,35119,0.0109650693242714,0.0359629091088518,-0.0595222325290782,0.0814523711776211,0.7604534891881
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29177.Quick recovery from stressful events,35119,-0.00518181597292129,0.0374182559638373,-0.0785215976620424,0.0681579657161998,0.889862913626237
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29178.Hard to snap back when something bad happens,35119,-0.0132532865634073,0.0363680572235449,-0.0845346787215554,0.0580281055947407,0.715556610506866
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29179.Comes through difficult times with little trouble,35119,0.00326718315205636,0.0370755630100521,-0.0694009203476457,0.0759352866517584,0.92978246785175
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29180.Tendency to take a long time to get over setbacks,35119,0.0308589056602025,0.0363213011546715,-0.0403308446029536,0.102048655923359,0.395576831381202
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29181.General happiness,35088,-0.0196109588814966,0.0379791042171223,-0.0940500031470564,0.0548280853840631,0.605621120407638
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29182.Belief that own life is meaningful,34999,0.0340998554453611,0.0377647513969142,-0.0399190572925908,0.108118768183313,0.366587483588203
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35482,-0.00351296352451076,0.0348065485104521,-0.0717337986049969,0.0647078715559754,0.919610646686795
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2946.Father's age,30144,-0.0269125088216756,0.0406706834091885,-0.106627048303685,0.0528020306603338,0.508312660708621
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2966.Age high blood pressure diagnosed,36655,-0.0240266663636562,0.00869831178283258,-0.041075357458008,-0.00697797526930432,0.0057550001420868
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30000.White blood cell (leukocyte) count,51193,0.00860248401383869,0.00488003891090141,-0.000962392251528079,0.0181673602792055,0.0779497898110204
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51194,-0.0196844557348623,0.00513881718312459,-0.0297565374137865,-0.00961237405593806,0.000128216108846774
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30020.Haemoglobin concentration,51194,-0.0191351682784218,0.00552103727357441,-0.0299564013346277,-0.00831393522221599,0.000529537149457284
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30030.Haematocrit percentage,51194,-0.0179153862907395,0.00537174226483644,-0.0284440011298189,-0.00738677145166008,0.000854046190876805
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30040.Mean corpuscular volume,51194,0.00849268871087052,0.00470898876435842,-0.000736929267271985,0.017722306689013,0.071322485200591
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51194,0.0070988305252462,0.00472843236668827,-0.0021688969134628,0.0163665579639552,0.133290422135125
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51194,-0.0030789209580172,0.00462800391830888,-0.0121498086379026,0.0059919667218682,0.50587804744943
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51194,0.0317156669419218,0.00476693816508518,0.0223724681383549,0.0410588657454888,2.9341413981481e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30080.Platelet count,51194,-0.0123177530934361,0.00468196378429202,-0.0214944021106485,-0.00314110407622379,0.00852198017151668
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30090.Platelet crit,51194,-5.94628282318992e-05,0.0047635087018751,-0.00939593988390709,0.00927701422744329,0.990040387405046
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51194,0.0222201397787034,0.00445842145297826,0.013481633730866,0.0309586458265408,6.28018808068207e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30110.Platelet distribution width,51194,0.0276085499735974,0.00462621556783272,0.0185411674606453,0.0366759324865496,2.44085174699333e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30120.Lymphocyte count,51156,-0.00548004505564775,0.00459753224752275,-0.0144912082607923,0.00353111814949683,0.233292323956655
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30130.Monocyte count,51156,0.0361848217382643,0.0047010202503185,0.0269708220476401,0.0453988214288886,1.44902271224338e-14
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30140.Neutrophill count,51156,0.00317191547722852,0.00482825325529622,-0.00629146090315207,0.0126352918576091,0.511220683061371
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30150.Eosinophill count,51156,0.0384707676868239,0.00460278244706115,0.0294493140905841,0.0474922212830638,6.74445650925169e-17
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30160.Basophill count,51156,0.0248693761209996,0.0206807874294461,-0.0156649672407147,0.0654037194827139,0.229169178036023
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30170.Nucleated red blood cell count,51156,0.0317299247014308,0.103647411257901,-0.171419001364056,0.234878850766917,0.759506051669871
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30180.Lymphocyte percentage,51157,-0.0125796524543012,0.0045795515399851,-0.021555573472672,-0.00360373143593036,0.00602071956319704
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30190.Monocyte percentage,51157,0.0343970025122751,0.00464111037285781,0.0253004261814738,0.0434935788430764,1.29518377600831e-13
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30200.Neutrophill percentage,51157,-0.00589101595544228,0.00454528994652769,-0.0147997842506366,0.003017752339752,0.194964835977761
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30210.Eosinophill percentage,51157,0.0361304745677734,0.00456718734671319,0.0271787873682156,0.0450821617673313,2.67580829497753e-15
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30220.Basophill percentage,51157,0.00465683201753984,0.00456313820765354,-0.00428691886946109,0.0136005829045408,0.307487102679237
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30230.Nucleated red blood cell percentage,51156,0.0316053954134759,0.103690828111405,-0.171628627684878,0.234839418511829,0.760518203927191
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30240.Reticulocyte percentage,50818,0.0101638835099107,0.00493882808019351,0.000483780472731406,0.01984398654709,0.0396064588100173
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30250.Reticulocyte count,50818,0.00534673555606438,0.00502564223627548,-0.00450352322703556,0.0151969943391643,0.287389959471899
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30260.Mean reticulocyte volume,50818,0.0231945508458436,0.00461302076472179,0.0141530301469889,0.0322360715446983,4.9942285930347e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30270.Mean sphered cell volume,50818,0.0115636993523782,0.00467375287334526,0.0024031437206215,0.0207242549841349,0.0133619075390854
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30280.Immature reticulocyte fraction,50818,0.00704639825436425,0.00487205551742091,-0.00250283055978072,0.0165956270685092,0.14811077135272
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50818,0.0117933233092066,0.00503488708545809,0.00192494462170878,0.0216617019967045,0.0191732295391414
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30300.High light scatter reticulocyte count,50818,0.00845771591336275,0.00510133892191921,-0.00154090837359889,0.0184563402003244,0.0973440007240594
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30500.Microalbumin in urine,37035,0.0594618713817435,0.00762854959211655,0.0445099141811951,0.074413828582292,7.28892160615784e-15
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51176,-0.00137319277171841,0.00509113970635485,-0.0113518265961739,0.00860544105273709,0.787376607247166
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30520.Potassium in urine,51139,-0.0173269145881657,0.00477381172860432,-0.0266835855762302,-0.00797024360010121,0.000284531643786468
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30530.Sodium in urine,51120,-0.0109534992797561,0.00501813687187672,-0.0207890475486345,-0.00111795101087776,0.0290624321917906
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30600.Albumin,48989,-0.0689778704542399,0.00492065731277626,-0.0786223587872813,-0.0593333821211984,1.97298222112978e-44
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30610.Alkaline phosphatase,50776,0.0754917997122029,0.00484860969583354,0.0659885247083691,0.0849950747160366,2.30844667382143e-54
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30620.Alanine aminotransferase,50780,0.0143335733718101,0.00519082042786894,0.00415956533318695,0.0245075814104332,0.00576149337970328
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30630.Apolipoprotein A,48849,-0.073708274928603,0.00537515801713145,-0.0842435846421806,-0.0631729652150253,1.33763117099364e-42
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30640.Apolipoprotein B,50676,-0.0325825401791086,0.00452335430039677,-0.0414483146078863,-0.0237167657503309,6.07654774769172e-13
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30650.Aspartate aminotransferase,50717,0.0447988946724739,0.00495736658232828,0.0350824561711104,0.0545153331738373,1.74560408777764e-19
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30660.Direct bilirubin,47611,0.0170291817153138,0.00526142688072976,0.00671678502908345,0.0273415784015441,0.00121172806706162
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30670.Urea,50764,0.0328614008771268,0.0047882796749784,0.0234763727141691,0.0422464290400844,6.93145907041731e-12
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30680.Calcium,48992,-0.0245055029792251,0.00477491973733517,-0.0338643456644021,-0.0151466602940482,2.8919116550902e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30690.Cholesterol,50782,-0.0453767249279235,0.004562054107797,-0.0543183509792056,-0.0364350988766414,2.92961326180134e-23
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30700.Creatinine,50775,0.0511424481712048,0.00529853735349202,0.0407573149583605,0.0615275813840492,5.33094128670167e-22
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30710.C-reactive protein,50718,0.050206161200101,0.00517991360144333,0.0400535305412721,0.0603587918589299,3.60289668353483e-22
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30720.Cystatin C,50789,0.12798713466582,0.0051959662424847,0.11780304083055,0.13817122850109,3.81520603899325e-132
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30730.Gamma glutamyltransferase,50776,0.0208607916798275,0.00522936686121333,0.0106112326318493,0.0311103507278056,6.65258245137103e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30740.Glucose,48973,0.026019796856853,0.00489717258616739,0.016421338587965,0.0356182551257411,1.08865731145857e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50738,0.0255024624863072,0.00499536511333322,0.0157115468641741,0.0352933781084403,3.33212330165232e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30760.HDL cholesterol,48980,-0.0766727985227303,0.00552731845110255,-0.0875063426868913,-0.0658392543585693,1.50572720598065e-43
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30770.IGF-1,50658,-0.0335540994813188,0.00475933058588479,-0.042882387429653,-0.0242258115329847,1.84116360866087e-12
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30780.LDL direct,50733,-0.0354038709933427,0.00447335218000826,-0.0441716412661589,-0.0266361007205265,2.60389085257917e-15
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30790.Lipoprotein A,46400,-0.00645863456180676,0.00511216421892678,-0.0164784764309033,0.00356120730728973,0.206467761756919
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30810.Phosphate,48951,0.000622171986313491,0.00511925179017563,-0.00941156152243074,0.0106559054950577,0.903267954645741
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30830.SHBG,48821,0.0197441177866482,0.00594881751682679,0.00808443545366767,0.0314038001196287,0.000905052704406951
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30840.Total bilirubin,50695,0.00183254280428899,0.00502396044433081,-0.0080144196665994,0.0116795052751774,0.715293708924969
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30850.Testosterone,48247,0.0050243985631922,0.00792487011754532,-0.0105083468671966,0.020557143993581,0.526085888030386
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30860.Total protein,48975,0.0675383760374429,0.00477426594584268,0.0581808147835912,0.0768959372912946,3.26900996906187e-45
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30870.Triglycerides,50769,0.0185465137702549,0.00521782087628523,0.0083195848527358,0.0287734426877739,0.000379571534331872
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30880.Urate,50749,0.0486560270107191,0.00559888802053828,0.037682206490464,0.0596298475309741,3.86810465096491e-18
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30890.Vitamin D,49687,-0.0100322407404415,0.0052928229959094,-0.0204061738124239,0.000341692331540884,0.0580478831440252
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3137.Number of measurements made,49349,-0.00658763133858141,0.0244246801591475,-0.0544600044505106,0.0412847417733477,0.787384526115647
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3143.Ankle spacing width,42013,0.013301596942857,0.0079452445332131,-0.00227108234224068,0.0288742762279547,0.0941238909616301
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42012,-0.0138811167905038,0.00620254978000383,-0.0260381143593114,-0.00172411922169635,0.0252401543538727
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3146.Speed of sound through heel,42013,-0.016726313964801,0.00594242816468406,-0.0283734731675818,-0.00507915476202025,0.00488930878068354
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42013,-0.0164581082280167,0.00601639865938783,-0.0282502496004168,-0.00466596685561654,0.00623633991254057
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3148.Heel bone mineral density (BMD),42001,-0.0175591216627237,0.00602843034918107,-0.0293748451471186,-0.00574339817832882,0.00358916173428525
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3526.Mother's age at death,48007,-0.000299474917005846,0.00480447131092265,-0.00971623868641424,0.00911728885240255,0.950298675064047
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3581.Age at menopause (last menstrual period),38313,-0.00580507251694641,0.00653611930959937,-0.0186158663637612,0.00700572132986836,0.374481999226814
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32744,-0.0105890602970819,0.0105725110925177,-0.0313111820384167,0.0101330614442528,0.3166218473239
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4100.Ankle spacing width (left),36623,0.0227854022119802,0.0109005442585392,0.00142033546524335,0.0441504689587171,0.0366248142780491
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36620,-0.031087207814051,0.00846651545434414,-0.0476815781045655,-0.0144928375235365,0.000242555596968751
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4103.Speed of sound through heel (left),36623,-0.0321341099845351,0.00808573605549888,-0.0479821526533129,-0.0162860673157573,7.12929618895597e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36623,-0.0331815780523543,0.00819151163316394,-0.0492369408533557,-0.017126215251353,5.15784669576149e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4105.Heel bone mineral density (BMD) (left),36618,-0.0331513917995555,0.00819542407922561,-0.0492144229948377,-0.0170883606042733,5.28284751726889e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36623,-0.033178343481691,0.00819148594024161,-0.0492336559245646,-0.0171230310388175,5.16625918867789e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4119.Ankle spacing width (right),36623,0.0203740766581642,0.0107768991524628,-0.00074864568066282,0.0414967989969912,0.0587256778199142
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36622,-0.0290183805216626,0.00845925739909782,-0.0455985250238943,-0.0124382360194309,0.000606039684958888
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4122.Speed of sound through heel (right),36623,-0.0324279515692023,0.00807698850797947,-0.0482588490448421,-0.0165970540935626,6.00672528950268e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36623,-0.03212006453319,0.00818805757963408,-0.0481686573892728,-0.0160714716771072,8.83166308377622e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4124.Heel bone mineral density (BMD) (right),36618,-0.0299397500503151,0.00817813543780226,-0.0459688955084075,-0.0139106045922226,0.000253026780968423
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36623,-0.0321179424338306,0.00818805569860578,-0.0481665316030979,-0.0160693532645633,8.84111878980412e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4194.Pulse rate,36968,0.0176268873194839,0.00770995833276151,0.00251536898727133,0.0327384056516965,0.0222664474344675
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4195.Pulse wave reflection index,36968,-0.00281341446715563,0.0083680197110325,-0.0192147331007793,0.0135879041664681,0.736721355890962
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4196.Pulse wave peak to peak time,36962,-0.0161837622369446,0.00761120112854587,-0.0311017164488945,-0.00126580802499474,0.0335090165299279
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4198.Position of the pulse wave peak,36968,0.0119698715594438,0.00811559806223988,-0.0039367006425464,0.0278764437614339,0.140274095642911
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4199.Position of pulse wave notch,36968,0.00935039626014196,0.00779771854406886,-0.00593313208623301,0.0246339246065169,0.230518035802634
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4200.Position of the shoulder on the pulse waveform,36968,0.0201947796009944,0.00799090256025783,0.00453261058288902,0.0358569486190997,0.0115165620831084
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4269.Number of triplets attempted (left),36787,0.0912344062380573,0.090045064467102,-0.0852539201174627,0.267722732593577,0.31099302347705
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4270.Volume level set by participant (left),36697,-0.00142693365109769,0.0309623196170284,-0.0621130801004733,0.0592592127982779,0.963242823687089
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4276.Number of triplets attempted (right),36781,0.0373756465210793,0.0895873934064717,-0.138215644555605,0.212966937597764,0.676545696788809
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4277.Volume level set by participant (right),36687,0.0344315014934611,0.0312395754883351,-0.0267980664636756,0.0956610694505979,0.27042070126135
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4288.Time to answer,36975,-0.00330232668544173,0.00908653004277674,-0.0211119255692841,0.0145072721984007,0.716292822277987
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4290.Duration screen displayed,36975,0.0160154328327021,0.00858999067327522,-0.000820948886917312,0.0328518145523215,0.0622990250058127
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X46.Hand grip strength (left),51774,-0.0344441208350078,0.00655894101191608,-0.0472996452183633,-0.0215885964516523,1.52251706631839e-07
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X47.Hand grip strength (right),51800,-0.0343930950328229,0.00651604059852614,-0.0471645346059341,-0.0216216554597116,1.31648373007745e-07
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X48.Waist circumference,51861,0.0302018513619804,0.00996439581922992,0.0106716355562898,0.0497320671676711,0.00244039082672015
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X4803.Tinnitus,36877,-0.0242692442671051,0.0349131463750824,-0.0926990111622665,0.0441605226280563,0.486993630782415
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4825.Noisy workplace,36954,0.0585808381314151,0.0406369842175802,-0.0210676509350421,0.138229327197872,0.149465602087905
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4836.Loud music exposure frequency,36909,-0.000444818713187882,0.0675642556855825,-0.13287075985693,0.131981122430554,0.994747223775574
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X49.Hip circumference,51856,-0.00575826521975255,0.00811086571983155,-0.0216555620306224,0.0101390315911173,0.477745803956857
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X50.Standing height,51836,0.0202067360746462,0.006444502014994,0.00757551212525796,0.0328379600240345,0.00171780839014399
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X5057.Number of older siblings,35760,-0.0338391093488355,0.0334651363037253,-0.0994307765041371,0.0317525578064662,0.311969942704903
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X51.Seated height,51750,0.0152051414755679,0.00602054559340696,0.00340487211249027,0.0270054108386455,0.0115587843902758
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5181.Ever had eye surgery,34408,-0.0231712831872318,0.0696250628667423,-0.159636406406047,0.113293840031583,0.739297968098439
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5186.Duration visual-acuity screen displayed (right),34394,0.00824298452179677,0.00930528299990029,-0.00999537015800779,0.0264813392016013,0.375745140830642
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5188.Duration visual-acuity screen displayed (left),34394,0.0115000613248911,0.00956042193803966,-0.00723836567366663,0.0302384883234488,0.229076676273614
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5190.Duration at which refractometer first shown (right),34320,0.0100962017385841,0.00984008389865937,-0.00919036270278823,0.0293827661799565,0.304926793888325
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5193.Duration at which refractometer first shown (left),34319,0.00964292163292874,0.00991094115306804,-0.00978252302708462,0.0290683662929421,0.330620488535237
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5199.logMAR, initial (right)",34379,0.0653709654392552,0.0394437719860232,-0.0119388276533503,0.142680758531861,0.0975152375683019
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5200.Final number of letters displayed (right),34379,0.366177749409128,0.215860391653167,-0.0569086182310789,0.789264117049336,0.089877058568257
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5201.logMAR, final (right)",34325,0.00914355277136013,0.0102806794486211,-0.0110065789479372,0.0292936844906575,0.373834205100559
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5202.Number of rounds to result (right),34379,0.0396536416610131,0.0369951009764929,-0.032856756252913,0.112164039574939,0.283832028374073
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5206.logMAR, initial (left)",34375,0.0449951327236976,0.0404344629214174,-0.0342564146022805,0.124246680049676,0.265849559947925
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5207.Final number of letters displayed (left),34375,-0.00157901357116662,0.221576591568884,-0.435869133046179,0.432711105903846,0.994314385553811
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5208.logMAR, final (left)",34315,0.00890521154190121,0.0102324411071905,-0.0111503730281921,0.0289607961119946,0.38418164673128
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5209.Number of rounds to result (left),34373,0.0183068889896791,0.0369748425659506,-0.054163802439584,0.0907775804189422,0.620538281009248
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34123,-0.011466851455318,0.00955269950193759,-0.0301901424791157,0.00725643956847966,0.230050210039559
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34123,-0.0143606126726694,0.0096439612602839,-0.0332627767428259,0.00454155139748701,0.136530749709309
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5256.Corneal hysteresis (right),34123,-0.0045368151370872,0.00966332504870915,-0.0234769322325571,0.0144033019583827,0.638741628493545
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5257.Corneal resistance factor (right),34123,-0.0114667249963362,0.0097546458589379,-0.0305858308798545,0.0076523808871821,0.23984582570546
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34118,-0.0114048274455245,0.00951541044774497,-0.0300550319231046,0.00724537703205568,0.230755243601445
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34118,-0.0197039610118331,0.00961674688897803,-0.03855278491423,-0.000855137109436136,0.0405226668048079
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5264.Corneal hysteresis (left),34118,-0.00519309871197092,0.00978209284001987,-0.0243660006784099,0.013979803254468,0.595527208008703
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5265.Corneal resistance factor (left),34118,-0.0140072742172989,0.00981772281684335,-0.0332500109383118,0.0052354625037141,0.153720122846902
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34522,-0.096130876866129,0.210440233171011,-0.508593733881311,0.316331980149053,0.647827357017621
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51804,-0.0184035212205199,0.0243608915866823,-0.0661508687304171,0.0293438262893774,0.449984782407237
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51804,0.0114151593752243,0.0260128616024096,-0.0395700493654985,0.0624003681159471,0.660790715885163
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51804,0.0448137199059208,0.0687630525532039,-0.0899618630983589,0.1795893029102,0.514593478353118
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51804,-0.00416610654440974,0.0104503333437541,-0.0246487598981678,0.0163165468093483,0.690149155985104
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51804,-0.00479502679903886,0.00984528094801274,-0.0240917774571438,0.0145017238590661,0.626236061780751
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38109,0.0050255472071526,0.0143998348503421,-0.023198129099518,0.0332492235138232,0.727097299237036
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38109,-0.0311770244674404,0.0309296777992939,-0.0917991929540564,0.0294451440191757,0.313483228246272
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38109,-0.0226370094293964,0.0378401943793086,-0.0968037904128412,0.0515297715540484,0.549703966774795
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38109,0.0116368881193038,0.0204342211325647,-0.028414185300523,0.0516879615391307,0.569044526529288
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51872,0.0441586722973761,0.0204211080863494,0.00413330044813131,0.0841840441466208,0.0305975211067634
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51872,0.0441586722973761,0.0204211080863494,0.00413330044813131,0.0841840441466208,0.0305975211067634
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51872,-0.00629979358974973,0.0163866535255713,-0.0384176344998695,0.02581804732037,0.700651056086581
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51872,-0.0565326388190151,0.0283500767471338,-0.112098789243397,-0.000966488394632911,0.0461540408585162
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51872,-0.0594498079134883,0.0674991491948856,-0.191748140335464,0.0728485245084874,0.378463024646573
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51872,0.00128506339663903,0.0464338573275256,-0.0897252969653111,0.0922954237585892,0.977921496844705
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51872,0.0587903992781226,0.0774914134249412,-0.0930927710347622,0.210673569591007,0.448057959359114
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51804,0.0186826659136866,0.0152051301269327,-0.0111193891351015,0.0484847209624747,0.219194072237041
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51804,0.0512320089960501,0.0254875781106832,0.00127635589911113,0.101187662092989,0.0444348349903747
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51804,0.0263536930274248,0.0151532418499866,-0.00334666099854903,0.0560540470533985,0.082022775240815
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51804,0.0305614719462552,0.0213719016553432,-0.0113274552982174,0.0724503991907278,0.152735502518017
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51804,0.00530376199278092,0.0259879362343344,-0.0456325930265146,0.0562401170120764,0.838288490977673
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51804,0.0467257008568466,0.0101294191819203,0.0268720392602828,0.0665793624534104,3.99321973445345e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38699,0.0301098560630638,0.0234746194947208,-0.0159003981465888,0.0761201102727165,0.199643980903194
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38699,-0.0285904725738567,0.0200607600693314,-0.0679095623097462,0.0107286171620328,0.154133998643202
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38699,0.0441562626795273,0.0288348627065175,-0.0123600682252469,0.100672593584302,0.125716230947598
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38699,0.0371913976611127,0.0226805657710353,-0.00726251125011659,0.0816453065723419,0.101081629889237
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51789,0.0440790320723396,0.0347444834163249,-0.0240201554236572,0.112178219568336,0.204574441198242
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51789,0.0132362136910896,0.0527857424410889,-0.0902238414934447,0.116696268875624,0.802006915813734
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51789,0.252663589067988,0.0848992640172178,0.0862610315942414,0.419066146541735,0.00292306082959623
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51789,0.137084683639539,0.0884863188491858,-0.036348501304865,0.310517868583943,0.121343096457388
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51789,-0.00164355023797401,0.0286355821364502,-0.0577692912254164,0.0544821907494684,0.954230747355229
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51789,-0.045055090067156,0.0399574258026222,-0.123371644640296,0.0332614645059835,0.259510411572357
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51789,-0.00549236485508058,0.0209989726768101,-0.0466503513016284,0.0356656215914672,0.793667712633709
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35884,0.0278195965746444,0.0283397596650222,-0.027726332368799,0.0833655255180879,0.326310038343978
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35884,0.0174417046272635,0.029656712807104,-0.0406854524746603,0.0755688617291874,0.556471631504716
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35884,0.0714977002635057,0.0416984097104258,-0.0102311827689289,0.15322658329594,0.0864578322781079
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35884,0.00170237220905039,0.0174206896985061,-0.0324421796000216,0.0358469240181224,0.922156539718711
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40323,0.0154482172628843,0.013414423141038,-0.0108440520935501,0.0417404866193188,0.249505084981996
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40323,-0.0145559660670392,0.0158563584577132,-0.0456344286441571,0.0165224965100787,0.358644405518761
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40323,-0.0148053979149737,0.0131357082365786,-0.0405513860586677,0.0109405902287203,0.259719961046276
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40323,0.0173166558467268,0.0301225198308899,-0.0417234830218174,0.076356794715271,0.565388082449906
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40323,-0.000934664841485689,0.0168563512104187,-0.0339731132139063,0.0321037835309349,0.955781895539329
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40323,0.0309813503594995,0.0241192845368541,-0.0162924473327346,0.0782551480517335,0.198991924528497
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51804,-0.0201764303889771,0.0283202443980921,-0.0756841094092376,0.0353312486312833,0.476200678367134
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51804,0.010341634474321,0.0213907758352152,-0.0315842861627008,0.0522675551113427,0.628772177507373
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51804,0.105185513436814,0.05426534296468,-0.00117455877395874,0.211545585647587,0.0525923246874005
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51804,-0.0200502375723264,0.0199972042807422,-0.059244757962581,0.0191442828179283,0.316039510066335
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51804,-0.0399838524483019,0.0235291520070881,-0.0861009903821946,0.00613328548559078,0.0892703102773643
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51804,0.0468374795869191,0.02807691485277,-0.00819327352451003,0.101868232698348,0.09529291549818
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51804,0.0153761206642145,0.00946038916335436,-0.00316624209596008,0.033918483424389,0.104109208693186
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34816,0.0440159984386381,0.023759059811265,-0.00255175879144123,0.0905837556687174,0.0639922936076305
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34816,0.0876158465543736,0.0292531112371875,0.0302797485294861,0.144951944579261,0.00275555050515858
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34816,-0.0227544383595168,0.0203927033760533,-0.0627241369765812,0.0172152602575475,0.264549978084097
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34816,-0.0127965452654833,0.0191431125138566,-0.0503170457926423,0.0247239552616757,0.503862769874663
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51896,0.0119757965197708,0.0126353808709766,-0.0127895499873434,0.0367411430268849,0.343242073094716
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51896,0.0468104712059802,0.0346768761330388,-0.0211562060147759,0.114777148426736,0.177060076459144
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51896,-0.0101773386285579,0.0105091700815766,-0.0307753119884479,0.0104206347313322,0.332842685100223
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51896,0.0081095353330958,0.0101183893811945,-0.0117225078540454,0.027941578520237,0.422870864615883
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51896,0.016013418583085,0.0172236689377228,-0.0177449725348516,0.0497718097010216,0.352519073479568
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51896,0.000417836679298344,0.0129067437103032,-0.024879380992896,0.0257150543514927,0.974174466855378
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51896,-0.0174848270575912,0.0105678858357867,-0.0381978832957332,0.0032282291805508,0.0980347937701651
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51896,0.0937520756839863,0.0324336048608831,0.0301822101566554,0.157321941211317,0.00384890553359469
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45339,-0.0374188472113815,0.0109811135602271,-0.0589418297894267,-0.0158958646333363,0.000657054834774453
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45339,0.0129384399188337,0.0114079887831942,-0.00942121809622691,0.0352980979338943,0.256745919691925
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45339,0.00841364368552481,0.012087209620136,-0.0152772871699417,0.0321045745409913,0.486389848521914
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45339,-0.000446679999346935,0.0164971203272789,-0.0327810358408136,0.0318876758421198,0.97839925970506
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45339,-0.0312911055483371,0.0110157409832,-0.052881957875409,-0.00970025322126515,0.00450877598690632
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51672,-0.0297672952731628,0.0110875510142857,-0.0514988952611628,-0.00803569528516277,0.00726374497902248
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51672,-0.0210922053939176,0.00899781414799717,-0.0387279211239921,-0.00345648966384319,0.0190792767332599
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51672,0.00813490539393675,0.0093130440833695,-0.0101186610094675,0.026388471797341,0.382402196559082
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51672,-0.0291433993771903,0.0201736048484196,-0.0686836648800928,0.0103968661257122,0.148575716251107
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51691,-0.0305397722071486,0.0099963548200294,-0.0501326276544062,-0.0109469167598909,0.00225255625837624
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51691,-0.0601106069086822,0.0197602653144099,-0.0988407269249255,-0.0213804868924389,0.0023528735629381
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51804,-0.0316853485105456,0.00913791470878273,-0.0495956613397598,-0.0137750356813315,0.000526379711808403
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51804,-0.0541634038668901,0.0104670847707533,-0.0746788900175666,-0.0336479177162135,2.30300258931811e-07
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51804,-0.012563995531871,0.0159119457334415,-0.0437514091694164,0.0186234181056744,0.429772508774777
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51804,-0.0227855343575686,0.0218978130169702,-0.0657052478708302,0.0201341791556931,0.298100555986841
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51804,0.0305735545074428,0.0277059676383573,-0.0237301420637374,0.084877251078623,0.269821534845144
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51804,-0.0720292242360352,0.0261352220394632,-0.123254259433383,-0.0208041890386874,0.00585560815273485
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42013,-0.0164564700776209,0.00601637833689831,-0.0282485716179416,-0.00466436853730023,0.00624132308591539
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X864.Number of days or week walked 10+ minutes,51311,-0.0168794429263085,0.0188841207320876,-0.0538923195612003,0.0201334337085833,0.37141551982844
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X874.Duration of walks,48263,-0.0102519096696217,0.00496025508834068,-0.0199740096427694,-0.000529809696473928,0.0387654343659753
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50379,-0.0403540650571848,0.0182051665637967,-0.0760361915222264,-0.00467193859214333,0.0266591685995573
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X894.Duration of moderate activity,45607,-0.00598914471590751,0.0224094576173101,-0.0499116816458353,0.0379333922140203,0.789272578408051
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X90087.No-wear time bias adjusted average acceleration,33372,-0.00930621923498402,0.0115277078078848,-0.0319005265384381,0.0132880880684701,0.419544580043884
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50296,-0.0494844084500242,0.0187144329814948,-0.086164697093754,-0.0128041198062945,0.00819486708223593
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X914.Duration of vigorous activity,40187,0.00398539210124347,0.00607521805493841,-0.00792203528643582,0.0158928194889228,0.511832658267759
